{"version": "synthetic", "data": [{"title": "synthetic", "paragraphs": [{"context": "...and risk screening to prevent the spread of COVID-19 Second, screening depends on whether exposure risk factors exist that would facilitate specific and reasonably sensitive case detection by questionnaire. For COVID-19, there is so far limited evidence for specific risk factors; we therefore assumed that at most 40% of travellers would be aware of a potential exposure. It is plausible that many individuals aware of a potential exposure would voluntarily avoid travel and practice social distancing-if so, the population of infected travellers will be skewed toward...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 0, "answer": "For COVID-19, there is so far limited evidence for specific risk factors; we therefore assumed that at most 40% of travellers would be aware of a potential exposure."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...for COVID-19 mortality, adjusted to age and gender-specific prevalence of the morbidities reported in the CDC paper 11 , namely hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer. The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities. Besides these baseline characteristics, ethnicity also presented statistically significant odds ratios. The search performed in Pubmed on the 21 th of January 2020 using the following keywords ((\"odds ratio\"...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 1, "answer": "The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of increasing is very high. ORs for comorbidities were expected to be greater than 1, but once again the values are somehow greater than what one could have anticipated. The objective of this work was accomplished as adjusted ORs were obtained, which allows a direct comparison between risk factors and the assessment of their importance for the final outcome (dying from COVID-19). Analyzing the ORs, it can be learnt that elderly patients (above 60 years old) present the highest risk (OR=18.8161 CI95% [7.1997; 41 .5517]) to COVID-19, even ....", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 2, "answer": "The objective of this work was accomplished as adjusted ORs were obtained, which allows a direct comparison between risk factors and the assessment of their importance for the final outcome (dying from COVID-19)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...[2] [3] [4] [5] Thus, we must understand the mechanisms of heart-lung interactions in ARDS patients, particularly the right ventricle function impairments caused by respiratory dysfunction. 26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients. Indeed, the outcomes of these patients need to be further determined in long-term follow-up studies. Our study has some limitations. First, this is a modest-size case series of hospitalized...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 3, "answer": "26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...China, respiratory manifestations of the disease have been observed. However, as a fatal comorbidity, acute myocardial injury (AMI) in COVID-19 patients has not been previously investigated in detail. We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them. We analyzed data from 53 consecutive laboratory-confirmed and hospitalized COVID-19 patients (28 men, 25 women; age, 19-81 years). We collected information on epidemiological and demographic characteristics, clinical features, routine...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 4, "answer": "We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.23.20026864 doi: medRxiv preprint significantly higher mortality rate than women in SARS patients. Therefore, Gender is a risk factor for higher severity and mortality in patients with both COVID-19 and SARS independent of age and susceptibility. In early 2003, we participated in the Beijing Municipal Medical Taskforce of SARS 12 . Here, we re-analyzed the data of a large population of 520 SARS patients including...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 5, "answer": "Therefore, Gender is a risk factor for higher severity and mortality in patients with both COVID-19 and SARS independent of age and susceptibility."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...and risk of hip ON development. 9 On the contrary, in severe acute respiratory syndrome, risk of ON appeared to be correlated with the maximal corticosteroid daily dose used. 10 Tobacco smoking is a strong risk factor for many chronic pulmonary diseases, and current smoking itself has been associated with a relative risk for ON of 3.9-4.7. 16 17 Hepatic diseases have previously been associated with a 5.0-fold increase for incident ON 16 35 in accordance with our findings. Alcohol overuse is a known ON risk...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 6, "answer": "10 Tobacco smoking is a strong risk factor for many chronic pulmonary diseases, and current smoking itself has been associated with a relative risk for ON of 3.9-4.7."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...determine vulnerability of nations to COVID-19, the popular metric has been IDVI [1, 7] with [7] also employing WHO International Health Regulation Monitoring and Evaluation Framework to determine preparedness. For the current COVID-19 outbreak, [2] provides the relative import risk to various countries estimated using the worldwide air transportation network consisting of 4000 airports, and also an interactive visualization for arbitrary origin airports. Some key differences: (a) We use IATA data which contains passenger flow volume between origin-destination airports (including transit points) instead of OAG data (used by [3] ) which contains...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 7, "answer": "For the current COVID-19 outbreak, [2] provides the relative import risk to various countries estimated using the worldwide air transportation network consisting of 4000 airports, and also an interactive visualization for arbitrary origin airports."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...and critical patients in ALT elevation group was significantly higher. Multivariate logistic regression analysis showed CRP \u2265 20 mg/L and lymphocyte count< 1.1\u00d710^9/L were independently related to hepatic injury. Lymphopenia and CRP may serve as the risk factors related to hepatic injury in patients with COVID-19, which might be related to inflammatory cytokine storm in liver injury. Early detection and timely treatment of hepatic injury in patients with COVID-19 are necessary. The corona virus disease 2019 ( COVID- 19) , a severe public health issue in...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 8, "answer": "Lymphopenia and CRP may serve as the risk factors related to hepatic injury in patients with COVID-19, which might be related to inflammatory cytokine storm in liver injury."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...All the six patients had severe or critically severe NCP and required ICU care. Of the six AMI patients, three died, two remained hospitalized, and one was discharged. Notably, CRP levels, NCP severity, and underlying comorbidities were the major risk factors for AMI in the COVID-19 patients. Interestingly, there were 24 (45%) COVID-19 patients with elevation in the levels of one or more myocardial enzymes and markers of myocardial damage whose features did not meet the...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 9, "answer": "Notably, CRP levels, NCP severity, and underlying comorbidities were the major risk factors for AMI in the COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...that a disease's natural history, particularly the amount of transmission that occurs before symptoms, greatly influences the ability to control outbreaks and the relative effectiveness of these two strategies. Recent work on isolation for the 2019 Coronavirus Disease (COVID-19) found a potentially large impact of perfect isolation, if one assumed there was limited pre-symptomatic transmission and a high probability of tracing contacts to be put under isolation immediately following symptom onset. However, the estimates for the serial interval of COVID-19, which impacts the amount of pre-symptomatic transmission, are varied. As COVID-19 continues to spread, better understanding how to contain it...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 10, "answer": "Recent work on isolation for the 2019 Coronavirus Disease (COVID-19) found a potentially large impact of perfect isolation, if one assumed there was limited pre-symptomatic transmission and a high probability of tracing contacts to be put under isolation immediately following symptom onset."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...assess the microbiome in nasopharyngeal swabs obtained from patients with COVID-19 by the ISARIC 4C consortium. Mechanisms of life-threatening disease in COVID-19 including factors associated with morbidity and mortality. Middle East respiratory syndrome (MERS) can provide important parallels: one of the risk factors associated with severe disease and/or a fatal outcome is the presence of other infections [1, 2] . Other infections may therefore exacerbate COVID-19. A case study in China identified the presence of other microorganisms in patients with COVID-19 and included specific nucleic acid based detection for...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 11, "answer": "Middle East respiratory syndrome (MERS) can provide important parallels: one of the risk factors associated with severe disease and/or a fatal outcome is the presence of other infections [1, 2] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...China, respiratory manifestations of the disease have been observed. However, as a fatal comorbidity, acute myocardial injury (AMI) in COVID-19 patients has not been previously investigated in detail. We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them. We analyzed data from 53 consecutive laboratory-confirmed and hospitalized COVID-19 patients (28 men, 25 women; age, 19-81 years). We collected information on epidemiological and demographic characteristics, clinical features, routine...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 12, "answer": "We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...for COVID-19 mortality, adjusted to age and gender-specific prevalence of the morbidities reported in the CDC paper 11 , namely hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer. The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities. Besides these baseline characteristics, ethnicity also presented statistically significant odds ratios. The search performed in Pubmed on the 21 th of January 2020 using the following keywords ((\"odds ratio\"...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 13, "answer": "The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...history of exposure to the Huanan Seafood Market has been rapidly increasing. As of February 1, 2020, there were 14,380 confirmed cases of 2019 novel coronavirus disease in China. [3] A previous study found that highest temperature, dyspnea, respiratory rate, white blood cell count, neutrophil count, lymphocyte count, D-dimer, albumin, procalcitonin were risk factors for ICU care in patients with COVID-19. [4] Therefore, it is absolutely necessary to evaluate the possible factors affecting the progression of disease in COVID-19 patients. We investigated factors affecting the outcomes of COVID-19 patients to...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 14, "answer": "[3] A previous study found that highest temperature, dyspnea, respiratory rate, white blood cell count, neutrophil count, lymphocyte count, D-dimer, albumin, procalcitonin were risk factors for ICU care in patients with COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...screening out the ineligible cases, 54 patients were analyzed in this study. Results found that patients with higher NT-proBNP (above 88.64 pg/mL) level had more risks of inhospital death. After adjusting for potential cofounders in separate modes, NT-proBNP presented as an independent risk factor of in-hospital death in patients with severe COVID-19. : medRxiv preprint Figure 1. The NT-proBNP for in-hospital death of coronavirus disease 2019 (COVID-19) by receiver operating characteristic (ROC) curves. The area under the curve (AUC) of NT-proBNP was 0.909....", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 15, "answer": "After adjusting for potential cofounders in separate modes, NT-proBNP presented as an independent risk factor of in-hospital death in patients with severe COVID-19. : medRxiv preprint Figure 1."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...serum creatinine, blood urea nitrogen, urine creatinine, urine microalbumin and urine microglobulin et al to comprehensively assess renal function and determine the incidence of COVID-19 with early renal injury. The related risk factors of COVID-19 with early renal injury were also analyzed. A standardized case collection form was designed to collect laboratory data of the included patients. It mainly included the following items: (1) blood routine; (2) biochemical indexes of kidney,...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 16, "answer": "The related risk factors of COVID-19 with early renal injury were also analyzed."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...[2] [3] [4] [5] Thus, we must understand the mechanisms of heart-lung interactions in ARDS patients, particularly the right ventricle function impairments caused by respiratory dysfunction. 26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients. Indeed, the outcomes of these patients need to be further determined in long-term follow-up studies. Our study has some limitations. First, this is a modest-size case series of hospitalized...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 17, "answer": "26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...higher in the AMI patients than in patients with non-definite AMI (p<0.001). All the AMI patients required care in intensive care unit; of them, three died, two remain hospitalized. Multivariate analyses showed that C-reactive protein (CRP) levels, NCP severity, and underlying comorbidities were the risk factors for cardiac abnormalities in COVID-19 patients. All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The widespread outbreak of the Coronavirus Disease 2019...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 18, "answer": "Multivariate analyses showed that C-reactive protein (CRP) levels, NCP severity, and underlying comorbidities were the risk factors for cardiac abnormalities in COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...a small sample size retrospective study, which was limited by the small numbers of patients and by using a retrospective method. In particular, some important laboratory results were incomplete. In conclusion, the age and underlying diseases (hypertension, diabetes, etc.) is the most important risk factors for death of COVID-19. Bacterial infections may play an important role in promoting the death of patients. Malnutrition is common to severe patients. Multiple organ dysfunction can be observed, the most common organ...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 19, "answer": "In conclusion, the age and underlying diseases (hypertension, diabetes, etc.) is the most important risk factors for death of COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...and risk screening to prevent the spread of COVID-19 Second, screening depends on whether exposure risk factors exist that would facilitate specific and reasonably sensitive case detection by questionnaire. For COVID-19, there is so far limited evidence for specific risk factors; we therefore assumed that at most 40% of travellers would be aware of a potential exposure. It is plausible that many individuals aware of a potential exposure would voluntarily avoid travel and practice social distancing-if so, the population of infected travellers will be skewed toward...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 20, "answer": "For COVID-19, there is so far limited evidence for specific risk factors; we therefore assumed that at most 40% of travellers would be aware of a potential exposure."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...for COVID-19 mortality, adjusted to age and gender-specific prevalence of the morbidities reported in the CDC paper 11 , namely hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer. The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities. Besides these baseline characteristics, ethnicity also presented statistically significant odds ratios. The search performed in Pubmed on the 21 th of January 2020 using the following keywords ((\"odds ratio\"...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 21, "answer": "The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of increasing is very high. ORs for comorbidities were expected to be greater than 1, but once again the values are somehow greater than what one could have anticipated. The objective of this work was accomplished as adjusted ORs were obtained, which allows a direct comparison between risk factors and the assessment of their importance for the final outcome (dying from COVID-19). Analyzing the ORs, it can be learnt that elderly patients (above 60 years old) present the highest risk (OR=18.8161 CI95% [7.1997; 41 .5517]) to COVID-19, even ....", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 22, "answer": "The objective of this work was accomplished as adjusted ORs were obtained, which allows a direct comparison between risk factors and the assessment of their importance for the final outcome (dying from COVID-19)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...[2] [3] [4] [5] Thus, we must understand the mechanisms of heart-lung interactions in ARDS patients, particularly the right ventricle function impairments caused by respiratory dysfunction. 26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients. Indeed, the outcomes of these patients need to be further determined in long-term follow-up studies. Our study has some limitations. First, this is a modest-size case series of hospitalized...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 23, "answer": "26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...China, respiratory manifestations of the disease have been observed. However, as a fatal comorbidity, acute myocardial injury (AMI) in COVID-19 patients has not been previously investigated in detail. We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them. We analyzed data from 53 consecutive laboratory-confirmed and hospitalized COVID-19 patients (28 men, 25 women; age, 19-81 years). We collected information on epidemiological and demographic characteristics, clinical features, routine...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 24, "answer": "We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.23.20026864 doi: medRxiv preprint significantly higher mortality rate than women in SARS patients. Therefore, Gender is a risk factor for higher severity and mortality in patients with both COVID-19 and SARS independent of age and susceptibility. In early 2003, we participated in the Beijing Municipal Medical Taskforce of SARS 12 . Here, we re-analyzed the data of a large population of 520 SARS patients including...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 25, "answer": "Therefore, Gender is a risk factor for higher severity and mortality in patients with both COVID-19 and SARS independent of age and susceptibility."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...and risk of hip ON development. 9 On the contrary, in severe acute respiratory syndrome, risk of ON appeared to be correlated with the maximal corticosteroid daily dose used. 10 Tobacco smoking is a strong risk factor for many chronic pulmonary diseases, and current smoking itself has been associated with a relative risk for ON of 3.9-4.7. 16 17 Hepatic diseases have previously been associated with a 5.0-fold increase for incident ON 16 35 in accordance with our findings. Alcohol overuse is a known ON risk...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 26, "answer": "10 Tobacco smoking is a strong risk factor for many chronic pulmonary diseases, and current smoking itself has been associated with a relative risk for ON of 3.9-4.7."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...determine vulnerability of nations to COVID-19, the popular metric has been IDVI [1, 7] with [7] also employing WHO International Health Regulation Monitoring and Evaluation Framework to determine preparedness. For the current COVID-19 outbreak, [2] provides the relative import risk to various countries estimated using the worldwide air transportation network consisting of 4000 airports, and also an interactive visualization for arbitrary origin airports. Some key differences: (a) We use IATA data which contains passenger flow volume between origin-destination airports (including transit points) instead of OAG data (used by [3] ) which contains...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 27, "answer": "For the current COVID-19 outbreak, [2] provides the relative import risk to various countries estimated using the worldwide air transportation network consisting of 4000 airports, and also an interactive visualization for arbitrary origin airports."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...and critical patients in ALT elevation group was significantly higher. Multivariate logistic regression analysis showed CRP \u2265 20 mg/L and lymphocyte count< 1.1\u00d710^9/L were independently related to hepatic injury. Lymphopenia and CRP may serve as the risk factors related to hepatic injury in patients with COVID-19, which might be related to inflammatory cytokine storm in liver injury. Early detection and timely treatment of hepatic injury in patients with COVID-19 are necessary. The corona virus disease 2019 ( COVID- 19) , a severe public health issue in...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 28, "answer": "Lymphopenia and CRP may serve as the risk factors related to hepatic injury in patients with COVID-19, which might be related to inflammatory cytokine storm in liver injury."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...All the six patients had severe or critically severe NCP and required ICU care. Of the six AMI patients, three died, two remained hospitalized, and one was discharged. Notably, CRP levels, NCP severity, and underlying comorbidities were the major risk factors for AMI in the COVID-19 patients. Interestingly, there were 24 (45%) COVID-19 patients with elevation in the levels of one or more myocardial enzymes and markers of myocardial damage whose features did not meet the...", "qas": [{"question": "Is smoking a risk factor for COVID-19?", "id": 29, "answer": "Notably, CRP levels, NCP severity, and underlying comorbidities were the major risk factors for AMI in the COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...that a disease's natural history, particularly the amount of transmission that occurs before symptoms, greatly influences the ability to control outbreaks and the relative effectiveness of these two strategies. Recent work on isolation for the 2019 Coronavirus Disease (COVID-19) found a potentially large impact of perfect isolation, if one assumed there was limited pre-symptomatic transmission and a high probability of tracing contacts to be put under isolation immediately following symptom onset. However, the estimates for the serial interval of COVID-19, which impacts the amount of pre-symptomatic transmission, are varied. As COVID-19 continues to spread, better understanding how to contain it...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 30, "answer": "Recent work on isolation for the 2019 Coronavirus Disease (COVID-19) found a potentially large impact of perfect isolation, if one assumed there was limited pre-symptomatic transmission and a high probability of tracing contacts to be put under isolation immediately following symptom onset."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...assess the microbiome in nasopharyngeal swabs obtained from patients with COVID-19 by the ISARIC 4C consortium. Mechanisms of life-threatening disease in COVID-19 including factors associated with morbidity and mortality. Middle East respiratory syndrome (MERS) can provide important parallels: one of the risk factors associated with severe disease and/or a fatal outcome is the presence of other infections [1, 2] . Other infections may therefore exacerbate COVID-19. A case study in China identified the presence of other microorganisms in patients with COVID-19 and included specific nucleic acid based detection for...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 31, "answer": "Middle East respiratory syndrome (MERS) can provide important parallels: one of the risk factors associated with severe disease and/or a fatal outcome is the presence of other infections [1, 2] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...China, respiratory manifestations of the disease have been observed. However, as a fatal comorbidity, acute myocardial injury (AMI) in COVID-19 patients has not been previously investigated in detail. We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them. We analyzed data from 53 consecutive laboratory-confirmed and hospitalized COVID-19 patients (28 men, 25 women; age, 19-81 years). We collected information on epidemiological and demographic characteristics, clinical features, routine...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 32, "answer": "We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...for COVID-19 mortality, adjusted to age and gender-specific prevalence of the morbidities reported in the CDC paper 11 , namely hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer. The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities. Besides these baseline characteristics, ethnicity also presented statistically significant odds ratios. The search performed in Pubmed on the 21 th of January 2020 using the following keywords ((\"odds ratio\"...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 33, "answer": "The risk factors for MERS-CoV were established after analysing data collected from the World Health organization between 2012 and 2018 14 , where males seemed to be more affected than females, and also age over 30 years-old or the presence or comorbidities."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...history of exposure to the Huanan Seafood Market has been rapidly increasing. As of February 1, 2020, there were 14,380 confirmed cases of 2019 novel coronavirus disease in China. [3] A previous study found that highest temperature, dyspnea, respiratory rate, white blood cell count, neutrophil count, lymphocyte count, D-dimer, albumin, procalcitonin were risk factors for ICU care in patients with COVID-19. [4] Therefore, it is absolutely necessary to evaluate the possible factors affecting the progression of disease in COVID-19 patients. We investigated factors affecting the outcomes of COVID-19 patients to...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 34, "answer": "[3] A previous study found that highest temperature, dyspnea, respiratory rate, white blood cell count, neutrophil count, lymphocyte count, D-dimer, albumin, procalcitonin were risk factors for ICU care in patients with COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...screening out the ineligible cases, 54 patients were analyzed in this study. Results found that patients with higher NT-proBNP (above 88.64 pg/mL) level had more risks of inhospital death. After adjusting for potential cofounders in separate modes, NT-proBNP presented as an independent risk factor of in-hospital death in patients with severe COVID-19. : medRxiv preprint Figure 1. The NT-proBNP for in-hospital death of coronavirus disease 2019 (COVID-19) by receiver operating characteristic (ROC) curves. The area under the curve (AUC) of NT-proBNP was 0.909....", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 35, "answer": "After adjusting for potential cofounders in separate modes, NT-proBNP presented as an independent risk factor of in-hospital death in patients with severe COVID-19. : medRxiv preprint Figure 1."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...serum creatinine, blood urea nitrogen, urine creatinine, urine microalbumin and urine microglobulin et al to comprehensively assess renal function and determine the incidence of COVID-19 with early renal injury. The related risk factors of COVID-19 with early renal injury were also analyzed. A standardized case collection form was designed to collect laboratory data of the included patients. It mainly included the following items: (1) blood routine; (2) biochemical indexes of kidney,...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 36, "answer": "The related risk factors of COVID-19 with early renal injury were also analyzed."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...[2] [3] [4] [5] Thus, we must understand the mechanisms of heart-lung interactions in ARDS patients, particularly the right ventricle function impairments caused by respiratory dysfunction. 26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients. Indeed, the outcomes of these patients need to be further determined in long-term follow-up studies. Our study has some limitations. First, this is a modest-size case series of hospitalized...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 37, "answer": "26 Logistic regression analysis indicated that NCP severity was a risk factor for AMI in COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...higher in the AMI patients than in patients with non-definite AMI (p<0.001). All the AMI patients required care in intensive care unit; of them, three died, two remain hospitalized. Multivariate analyses showed that C-reactive protein (CRP) levels, NCP severity, and underlying comorbidities were the risk factors for cardiac abnormalities in COVID-19 patients. All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The widespread outbreak of the Coronavirus Disease 2019...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 38, "answer": "Multivariate analyses showed that C-reactive protein (CRP) levels, NCP severity, and underlying comorbidities were the risk factors for cardiac abnormalities in COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...a small sample size retrospective study, which was limited by the small numbers of patients and by using a retrospective method. In particular, some important laboratory results were incomplete. In conclusion, the age and underlying diseases (hypertension, diabetes, etc.) is the most important risk factors for death of COVID-19. Bacterial infections may play an important role in promoting the death of patients. Malnutrition is common to severe patients. Multiple organ dysfunction can be observed, the most common organ...", "qas": [{"question": "is pre-existing pulmonary disease a risk factor for COVID-19?", "id": 39, "answer": "In conclusion, the age and underlying diseases (hypertension, diabetes, etc.) is the most important risk factors for death of COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...infect a large variety of ruminants (4). Second, uncommon human transmissibility may also reflect usage of a protein that is present predominantly in the lower respiratory tracts of humans. Even though SARS-CoV caused a respiratory disease with high morbidity and mortality, it was not easily transmissible between humans, in part because its receptor, hACE2, is most abundant in the lungs and less so in the upper airway (5) . Consequently, most SARS-CoV-infected patients were not contagious until after they developed pneumonia, with spread occurring via large droplets. This resulted in a high proportion of secondary cases being close...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 40, "answer": "Even though SARS-CoV caused a respiratory disease with high morbidity and mortality, it was not easily transmissible between humans, in part because its receptor, hACE2, is most abundant in the lungs and less so in the upper airway (5) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Although researchers are racing against time to develop vaccines and test anti-viral drugs in clinical trials [8] , there is no effective prophylactic and clinical treatment for COVID-19 yet. Generally, the COVID-19 is less severe and less fatal than the SARS, however, some patients, especially aged populations with co-morbidities are prone to develop more severe symptoms and require emergent medical interventions [9] . It is not completely understood why some patients develop severe but others have mild or even asymptomatic diseases by the same SARS-CoV-2 infections. The immunopathogenesis of hCoVs-induced respiratory distress...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 41, "answer": "Generally, the COVID-19 is less severe and less fatal than the SARS, however, some patients, especially aged populations with co-morbidities are prone to develop more severe symptoms and require emergent medical interventions [9] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...to the swine industry [5] [6] [7] . Accumulating evidence indicates that this large-scale recurrence of PED was caused by highly virulent PEDV variants [8] [9] [10] [11] . In addition, co-infection of TGEV and PEDV often causes higher morbidity and mortality in newborn piglets. Therefore, the development of a safe and highly efficient vaccine against TGE and PED would be of great importance. It is now clear that the gastrointestinal mucosas are the...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 42, "answer": "In addition, co-infection of TGEV and PEDV often causes higher morbidity and mortality in newborn piglets."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...that older age was associated with a high mortality in patients with This is the first preliminary study investigating the gender role in morbidity and mortality of SARS-CoV-2 infection. It is suggested that COVID-19 is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as ARDS 10 . Among the 425 patients with COVID-19, 56% were male, indicating males may be more susceptible to SARS-CoV-2 infection than females 6 . In 140 hospitalized patients with COVID-19, an...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 43, "answer": "It is suggested that COVID-19 is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as ARDS 10 ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. Sarbecovirus, while the MERS-CoV to Merbecovirus. 13 SARS-CoV, MERS-CoV, and 2019-nCoV all cause diseases in humans but each subgroup may have mild different biologic characteristic and virulence. [5] [6] [7] The exact origin, location, and natural reservoir of the 2019-nCoV remain unclear, although it is believed that the virus is zoonotic and bats may be the...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 44, "answer": "13 SARS-CoV, MERS-CoV, and 2019-nCoV all cause diseases in humans but each subgroup may have mild different biologic characteristic and virulence."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...COVID-19 is a complex disease phenotype where the underlying microbiome could influence morbidity and mortality. Amplicon and metagenomic MinION based sequencing was used to rapidly (within 8 hours) identify SARS-CoV-2 and assess the microbiome in nasopharyngeal swabs obtained from patients with COVID-19 by the...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 45, "answer": "COVID-19 is a complex disease phenotype where the underlying microbiome could influence morbidity and mortality."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...causes were reported in Wuhan, Hubei Province, China [1] . On 7 January 2020, a novel coronavirus, named COVID-19, was identified as the cause of this outbreak [2] . This COVID-19 virus shares the common characteristics of coronavirus and is expected to become more virulent when establishing efficient human-to-human transmission [3] . The emergence of this virus coincided with the Spring Festival Travel Rush in China. It was estimated that there would be around 3 billion trips made in China during...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 46, "answer": "This COVID-19 virus shares the common characteristics of coronavirus and is expected to become more virulent when establishing efficient human-to-human transmission [3] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...or patients with significant comorbidities [2] . The vast majority of reported cases have been in adults, decreasing our ability to draw inferences and make recommendations for pediatric patients. Despite its apparent increased infectivity (R 0 =2.2) the 2019-nCoV strain appears to be less virulent than SARS-CoV (case-fatality rate=9.5%) and MERS-CoV (case-fatality rate=34.4%); currently reported case-fatality rate of 2019-nCoV is 2.2% [3] [4] . Superspreaders (R 0 >10) have been identified in both MERS-CoV and SARS-CoV outbreaks and there are similar reports of 2019-nCoV superspreaders [4] . One should be mindful of the...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 47, "answer": "Despite its apparent increased infectivity (R 0 =2.2) the 2019-nCoV strain appears to be less virulent than SARS-CoV (case-fatality rate=9.5%) and MERS-CoV (case-fatality rate=34.4%); currently reported case-fatality rate of 2019-nCoV is 2.2% [3] [4] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...framing of these principles in the context of the DHHS policy. The P3CO principles echo the Recommendations' guidance on federal department pre-funding review and approval of GOF/ PPP research. These principles apply to \"Gain of Function Research of Concern\" (GOFROC): GOF research that is (1) highly transmissible and likely capable of wide and uncontrollable spread in human populations and (2) highly virulent and likely to cause significant morbidity and/or mortality in humans (National Science Advisory Board for Biosecurity, 2016). Recommendations, P3CO, and the DHHS policy note that all principles must be satisfied in order to pursue GOFROC. The document also suggests other risk mitigation strategies should biosafety and/or...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 48, "answer": "These principles apply to \"Gain of Function Research of Concern\" (GOFROC): GOF research that is (1) highly transmissible and likely capable of wide and uncontrollable spread in human populations and (2) highly virulent and likely to cause significant morbidity and/or mortality in humans (National Science Advisory Board for Biosecurity, 2016)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...by caesarean section, 2 by vaginal delivery, 8 (42%) delivered pre-term. There was one neonatal death, in 15 babies who were tested there was no evidence of vertical transmission. CONCLUSIONS Morbidity and mortality from COVID-19 appears less marked than for SARS and MERS, acknowledging the limited number of cases reported to date. Pre-term delivery affected 42% of women hospitalised with COVID-19, which may put considerable pressure on neonatal services if the UK reasonable worse-case scenario of 80% of the population affected...", "qas": [{"question": "Does co-morbidities make COVID-19 more transmissible or virulent", "id": 49, "answer": "CONCLUSIONS Morbidity and mortality from COVID-19 appears less marked than for SARS and MERS, acknowledging the limited number of cases reported to date."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of the 2019 novel coronavirus disease (COVID-19) 1 has fast spread widely. By 19 February 2020, over 70 000 laboratory-confirmed COVID-19 have been reported, with over 1800 patients died. At least 12 neonates have been diagnosed with COVID-19. 2 Newborn infants deserve more concern due to their immature immune system and the possibility of mother to infant transmission. Neonatologists belonging to the Chinese Neonatologist Association of Chinese...", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 50, "answer": "At least 12 neonates have been diagnosed with COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...neonatal intensive care facilities as COVID-19 is associated with pre-term delivery in 50% of reported cases. In SARS and MERS-affected cases, delivery was most often indicated by maternal hypoxaemia. In COVID-19, if maternal illness is not as severe, the considerations will be based more on obstetric indications for delivery. Information on vertical transmission for COVID-19 is limited, although testing of 15 neonates born to mothers with COVID-19 has all been negative. Guidance on mode of delivery requires expert...", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 51, "answer": "In COVID-19, if maternal illness is not as severe, the considerations will be based more on obstetric indications for delivery."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...especially preterm infants, might be nonspecific, which might include temperature instability, gastrointestinal and cardiovascular dysfunction, and dominant respiratory problems. Some severe patients could rapidly develop acute respiratory distress syndrome. All infants with suspected COVID-19 should be isolated and monitored regardless of whether or not they present with symptoms. Diagnosis of neonatal COVID-19 could be confirmed if the suspected patients have positive nucleic acid test for COVID-19 from the respiratory tract, stool or blood specimens....", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 52, "answer": "All infants with suspected COVID-19 should be isolated and monitored regardless of whether or not they present with symptoms."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...in newborn infants By 19 February 2020, over 70 000 laboratory-confirmed COVID-19 have been reported, with over 1800 patients died. At least 12 neonates have been diagnosed with COVID-19. 2 Newborn infants deserve more concern due to their immature immune system and the possibility of mother to infant transmission. Neonatologists belonging to the Chinese Neonatologist Association of Chinese Doctor Association have proposed measurements for the prevention and control of COVID-19 in neonates....", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 53, "answer": "2 Newborn infants deserve more concern due to their immature immune system and the possibility of mother to infant transmission."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...cases, delivery was most often indicated by maternal hypoxaemia. In COVID-19, if maternal illness is not as severe, the considerations will be based more on obstetric indications for delivery. Information on vertical transmission for COVID-19 is limited, although testing of 15 neonates born to mothers with COVID-19 has all been negative. Guidance on mode of delivery requires expert consensus until further information emerges. There is evidence for vertical transmission of HCoV 229E, seroconversion was not investigated however and all infants...", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 54, "answer": "Information on vertical transmission for COVID-19 is limited, although testing of 15 neonates born to mothers with COVID-19 has all been negative."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...that they are born to mothers diagnosed with COVID-19, or have close contact with someone with probable or confirmed COVID-19, or live in or travel to the epidemic area. Clinical manifestations of infected neonates, especially preterm infants, might be nonspecific, which might include temperature instability, gastrointestinal and cardiovascular dysfunction, and dominant respiratory problems. Some severe patients could rapidly develop acute respiratory distress syndrome. All infants with suspected COVID-19 should be isolated and monitored regardless of whether or not they present with symptoms....", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 55, "answer": "Clinical manifestations of infected neonates, especially preterm infants, might be nonspecific, which might include temperature instability, gastrointestinal and cardiovascular dysfunction, and dominant respiratory problems."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...disease in newborn infants 3 Medical staff involved must be equipped with required protective equipment. Neonatal resuscitation is performed according to the Neonatal Resuscitation Program seventh edition as usual. Newborns are considered at high risk of COVID-19 in case that they are born to mothers diagnosed with COVID-19, or have close contact with someone with probable or confirmed COVID-19, or live in or travel to the epidemic area. Clinical manifestations of infected neonates, especially preterm infants, might be nonspecific, which might include temperature instability, gastrointestinal and cardiovascular dysfunction, and dominant respiratory problems....", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 56, "answer": "Newborns are considered at high risk of COVID-19 in case that they are born to mothers diagnosed with COVID-19, or have close contact with someone with probable or confirmed COVID-19, or live in or travel to the epidemic area."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Some severe patients could rapidly develop acute respiratory distress syndrome. All infants with suspected COVID-19 should be isolated and monitored regardless of whether or not they present with symptoms. Diagnosis of neonatal COVID-19 could be confirmed if the suspected patients have positive nucleic acid test for COVID-19 from the respiratory tract, stool or blood specimens. 4 Infants with highly suspected or confirmed COVID-19 should be referred to the designated neonatal ward. All medical staff involved should wear protective equipment....", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 57, "answer": "Diagnosis of neonatal COVID-19 could be confirmed if the suspected patients have positive nucleic acid test for COVID-19 from the respiratory tract, stool or blood specimens."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...CONCLUSIONS Morbidity and mortality from COVID-19 appears less marked than for SARS and MERS, acknowledging the limited number of cases reported to date. Pre-term delivery affected 42% of women hospitalised with COVID-19, which may put considerable pressure on neonatal services if the UK reasonable worse-case scenario of 80% of the population affected is realised. There has been no evidence of vertical transmission to date. The RCOG and RCPCH have provided interim guidance to help maternity and neonatal services plan their response to COVID-19....", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 58, "answer": "Pre-term delivery affected 42% of women hospitalised with COVID-19, which may put considerable pressure on neonatal services if the UK reasonable worse-case scenario of 80% of the population affected is realised."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...At least 12 neonates have been diagnosed with COVID-19. 2 Newborn infants deserve more concern due to their immature immune system and the possibility of mother to infant transmission. Neonatologists belonging to the Chinese Neonatologist Association of Chinese Doctor Association have proposed measurements for the prevention and control of COVID-19 in neonates. The delivery room or operating room serving suspected or confirmed infected mothers should be specially prepared, preferably with negative pressure. 3 Medical staff involved must be equipped with required...", "qas": [{"question": "Are Neonates more potential for COVID-19?", "id": 59, "answer": "Neonatologists belonging to the Chinese Neonatologist Association of Chinese Doctor Association have proposed measurements for the prevention and control of COVID-19 in neonates."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...benefits of treatment outweigh the risks of toxicity seen in animal studies. The use of Chloroquine outweighs the risks in the prevention and treatment of malaria during pregnancy (25). Remdesivir has been used for the treatment of Ebola in pregnant women(26), however it should be acknowledged that Ebola is a condition with a CFR of 50% for which there would be higher tolerance for adverse effects of a potentially beneficial treatment than would be the case for COVID-19 where the CFR is around 1%. It would seem reasonable not to exclude seriously ill pregnant women from trials of these therapies for COVID-19. There is a need for systematic data reporting on women affected...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 60, "answer": "Remdesivir has been used for the treatment of Ebola in pregnant women(26), however it should be acknowledged that Ebola is a condition with a CFR of 50% for which there would be higher tolerance for adverse effects of a potentially beneficial treatment than would be the case for COVID-19 where the CFR is around 1%."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Though adult females produce more robust inflammatory responses as compared to men, the opposite is true in infants and children. 26 Young males produce stronger inflammatory responses than females. 26 However, females, beginning at birth and persisting throughout adulthood, have higher numbers of CD4+ T cells and higher CD4/CD8 T cell ratios 26 , though the potential impact of this on COVID-19 infections is unknown. In respiratory syncytial virus (RSV) related illness, a common respiratory tract infection in young children, prevalence rates are reported to be the same in males and females, however, males...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 61, "answer": "26 However, females, beginning at birth and persisting throughout adulthood, have higher numbers of CD4+ T cells and higher CD4/CD8 T cell ratios 26 , though the potential impact of this on COVID-19 infections is unknown."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...in age distribution between the two groups of patients ( Table 1) Table 1 ). The result in the second group is not similar to that from previous studies. 7, 9 We speculate that this may be related to the small sample size, since there is no evidence that women are more vulnerable to infection as the COVID-19 spreads. In terms of the initial symptoms, more symptoms appeared in patients from the first group ( did not show obvious differences between the two groups, suggesting that patients admitted...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 62, "answer": "7, 9 We speculate that this may be related to the small sample size, since there is no evidence that women are more vulnerable to infection as the COVID-19 spreads."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...disease or the elderly are not only susceptible, but also often more serious. These patients are at higher risk of admission to intensive care or death [6, 7] . In addition, the profound impact inflicted by COVID-19 on pregnant women and newborns has also been noticed [8, 9] . However, as far as we know, the impact of COVID-19 epidemic on chronic kidney disease patients, especially uremic HD patients has not yet been reported....", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 63, "answer": "In addition, the profound impact inflicted by COVID-19 on pregnant women and newborns has also been noticed [8, 9] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...caesareans section, 1 at 24 weeks resulted in a neonatal death (birthweight 240g), 2 babies delivered at 32 weeks for maternal hypoxaemia have no outcomes reported (10, 18) . CONCLUSIONS There are limited data on the impact of the current COVID-19 outbreak on women affected in pregnancy and their babies. Studies were all case-reports or series and of low quality. Outcomes reported varied, one series on COVID-19 did not report on maternal outcomes. From the 10/19 women where maternal...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 64, "answer": "CONCLUSIONS There are limited data on the impact of the current COVID-19 outbreak on women affected in pregnancy and their babies."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...stages, 20 trials are exploratory studies or in the preliminary experiment Most of the subjects were limited to light (ordinary subjects), and few of the studies included severe patients. The common characteristics of the exclusion criteria are: severe and critical patients with COVID-19; pregnant and lactating women; allergic patients; patients with serious heart, brain, kidney, tumor, hemoglobin disease and other diseases; patients with mental disorders, drug abuse or dependence history; those who do not get informed consent; the researchers think the subject is not suitable. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity....", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 65, "answer": "The common characteristics of the exclusion criteria are: severe and critical patients with COVID-19; pregnant and lactating women; allergic patients; patients with serious heart, brain, kidney, tumor, hemoglobin disease and other diseases; patients with mental disorders, drug abuse or dependence history; those who do not get informed consent; the researchers think the subject is not suitable."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...usual outbreak control measures including early identification and management of persons with infection, tracing of contacts with monitoring for onset of fever and/or symptoms, and active engagement of communities. Most modelling suggests that the severity of illness is more like influenza than SARS, and there is concern among the public health community because the transmissibility of COVID-19 is not yet fully understood, and the potential for it to become endemic like other respiratory pathogens is unknown. Because of the many unknowns, the initial reaction by health agencies is still valid: to brace for the first wave as the virus reaches a completely na\u00efve population and...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 66, "answer": "Most modelling suggests that the severity of illness is more like influenza than SARS, and there is concern among the public health community because the transmissibility of COVID-19 is not yet fully understood, and the potential for it to become endemic like other respiratory pathogens is unknown."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...should not be fed with the breast milk from mothers with confirmed or suspected of 2019-nCoV.\" Guidance from the CDC is less clear but is still precautionary (23) . Expert consensus is needed for breastfeeding and the use of expressed breastmilk for infant feeding for mothers affected by COVID-19 until more informative data emerges and for deciding whether women with COVID-19 who are symptomatic, suggesting high viral load, should breastfeed babies with unknown status. If the UK reasonable worse-case scenario of 80% attack rate for the population is realised and 4% require hospitalisation, thousands of women during pregnancy will be affected at a...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 67, "answer": "Expert consensus is needed for breastfeeding and the use of expressed breastmilk for infant feeding for mothers affected by COVID-19 until more informative data emerges and for deciding whether women with COVID-19 who are symptomatic, suggesting high viral load, should breastfeed babies with unknown status."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Only 16% respondents found official websites reliable. Enhanced personal 36 hygiene practices and travel avoidance to China were frequently adopted (>77%) and considered 37 effective (>90%). The adoption of social-distancing measures was lower (39%-88%), and their drivers 38 for greater adoption include: being female (adjusted odds ratio [aOR]:1.27), living in the New 39 Territories (aOR:1.32-1.55), perceived as having good understanding of COVID-19 (aOR:1.84) and 40 being more anxious (aOR:1.07). 41 42 Discussion: Risk perception towards COVID-19 in the community was high. Most respondents are alert 43 to the disease progression, and adopt self-protective measures....", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 68, "answer": "The adoption of social-distancing measures was lower (39%-88%), and their drivers 38 for greater adoption include: being female (adjusted odds ratio [aOR]:1.27), living in the New 39 Territories (aOR:1.32-1.55), perceived as having good understanding of COVID-19 (aOR:1.84) and 40 being more anxious (aOR:1.07)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...second or third check before being diagnosed. Third, most of the data were from patients' medical records, with the potential of a few of them not being accurate enough. In conclusion, all people are susceptible to COVID-19, and older males and those with comorbid conditions are more likely to become severe cases. Even though COVID-19 is highly contagious, control measures have proven to be very effective. The study was designed by QG and ZD; FX, JW,JW and QG collected the epidemiological...", "qas": [{"question": "Are pregnant women more potential for COVID-19?", "id": 69, "answer": "In conclusion, all people are susceptible to COVID-19, and older males and those with comorbid conditions are more likely to become severe cases."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...On February 17, the State Council required localities to formulate differentiated county-level measures for precise containment of the COVID-19 outbreak and the restoration of socioeconomy affected by the outbreak. 22 The timing of implementing and lifting interventions is likely to have been and continue to be important, to take advantage of the window of opportunity to save lives and minimize the economic and social impact. 23, 24 The increasing numbers of cases of COVID-19 outside China and establishment of secondary transmission in multiple places highlights its pandemic potential....", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 70, "answer": "22 The timing of implementing and lifting interventions is likely to have been and continue to be important, to take advantage of the window of opportunity to save lives and minimize the economic and social impact."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...to make use of those new sets of databases. Appropriate protocols however have to be drafted to ensure effective actions while ensuring privacy and security of data and people. With scenarios like the present Coronavirus (COVID-19) outbreak, that not only impacts upon the economic status of cities, but also affects their social standing, it becomes imperative to emphasize the adoption of universal standards for data sharing. Such a move could have far reaching impact across cities and territories especially in positively combating outbreaks and disasters in a quicker, safer and standardized way, such that when...", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 71, "answer": "With scenarios like the present Coronavirus (COVID-19) outbreak, that not only impacts upon the economic status of cities, but also affects their social standing, it becomes imperative to emphasize the adoption of universal standards for data sharing."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...COVID-19 With the current severe outbreak of coronavirus disease emerging from Wuhan in China in late 2019, several countries worldwide battle to control the spread of this devastating virus. The ongoing outbreak is accompanied by many human casualties and significant socio-economic losses globally and has now reached the proportions of a pandemic, with more than 81,000 COVID-19 confirmed cases and more than 2,760 related fatalities worldwide (February 26, 2020) . Unfortunately, CoV-specific FDA-approved drugs are still not available in the clinics. In this study, to address the urgent unmet medical needs and to facilitate the development or identification of...", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 72, "answer": "The ongoing outbreak is accompanied by many human casualties and significant socio-economic losses globally and has now reached the proportions of a pandemic, with more than 81,000 COVID-19 confirmed cases and more than 2,760 related fatalities worldwide (February 26, 2020) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...COVID-19 is having a great impact on public health, mortality and economy worldwide, in spite of the efforts to prevent its epidemy. The SARS-CoV-2 genome is different from that of MERS-CoV and SARS-CoV, although also expected to spread differently according to meteorological conditions....", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 73, "answer": "COVID-19 is having a great impact on public health, mortality and economy worldwide, in spite of the efforts to prevent its epidemy."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...[19] [20] [21] The implementation of these NPIs has coincided with the rapid decline in the number of new cases across China, albeit at high economic and social costs. 15, 16 On February 17, the State Council required localities to formulate differentiated county-level measures for precise containment of the COVID-19 outbreak and the restoration of socioeconomy affected by the outbreak. 22 The timing of implementing and lifting interventions is likely to have been and continue to be important, to take advantage of the window of opportunity to save lives...", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 74, "answer": "15, 16 On February 17, the State Council required localities to formulate differentiated county-level measures for precise containment of the COVID-19 outbreak and the restoration of socioeconomy affected by the outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...quarantined for medical observation, and then ruled out of infection. For other regions in and out of China, the specific measures may be adjusted to the different social-political-economic environment. Based on the epidemic of COVID-19 in mainland China, we developed data-driven SEIQR models to investigate the impact of social distancing and epicenter lockdown on the epidemic dynamics. Activating social distancing at the possible earliest time with comprehensive and rigorous measures could significantly reduce the epidemic size of COVID-19....", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 75, "answer": "Based on the epidemic of COVID-19 in mainland China, we developed data-driven SEIQR models to investigate the impact of social distancing and epicenter lockdown on the epidemic dynamics."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...break out as a pandemic and the fear is that sustained-human-to-human transmission in a low-to-middle-income country could lead to massive numbers of patients with acute respiratory disease and death. Multiple countries have experienced cases of COVID-19, many with severe illness including a few deaths outside of China, and nearly all countries are experiencing the social and economic costs of this new outbreak. However, so long as current public health measures are sustained, the general population outside of China are unlikely to be exposed to this virus at the current time....", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 76, "answer": "Multiple countries have experienced cases of COVID-19, many with severe illness including a few deaths outside of China, and nearly all countries are experiencing the social and economic costs of this new outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...In the face of the catastrophic health emergency of COVID-19, medical personnel have been affected by different kinds of subjective and objective factors and confront several mental health problems. Mental illness is a form of human stress response, an explanatory, emotional, and defensive response within the human body, and a physiological response of the human body to the impact of needs or injuries. Therefore, this study aims to analyze the psychological state of medical personnel dealing with COVID-19 and its influencing factors in order to provide an objective basis for the prevention...", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 77, "answer": "Mental illness is a form of human stress response, an explanatory, emotional, and defensive response within the human body, and a physiological response of the human body to the impact of needs or injuries."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...How to potentially change these behaviours?). To successfully decrease the risk for a new SARS-CoV-2 outbreak or an outbreak of a similar virus, a One Health approach is crucial. In conclusion, SARS-CoV-2 which causes COVID-19 is continuing to cause global fears, psychological distress, economic losses and negative impacts on several human activities including industry and mobility. To date, SARS-CoV-2 does not represent a pandemic threat with the same severity as e.g. the 1918 Spanish influenza, but could still cause a high number of J o...", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 78, "answer": "In conclusion, SARS-CoV-2 which causes COVID-19 is continuing to cause global fears, psychological distress, economic losses and negative impacts on several human activities including industry and mobility."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...CNY and school holidays were also extended, with the holiday end date changed from January 30 to March 10 for Hubei province, and Feb 9 for many other provinces. [19] [20] [21] The implementation of these NPIs has coincided with the rapid decline in the number of new cases across China, albeit at high economic and social costs. 15, 16 On February 17, the State Council required localities to formulate differentiated county-level measures for precise containment of the COVID-19 outbreak and the restoration of socioeconomy affected by...", "qas": [{"question": "What are Socio-economic factors and economic impact of COVID-19?", "id": 79, "answer": "[19] [20] [21] The implementation of these NPIs has coincided with the rapid decline in the number of new cases across China, albeit at high economic and social costs."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings. 4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons. First, government engagement in the control of the outbreak has been unprecedented, for example, locking down Wuhan and surrounding cities, building new hospitals to treat infected patients in Wuhan...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 80, "answer": "4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...they are at high risk of exposure to the disease. Moreover, they have a deep understanding of the dangers of COVID-19, so they are prone to anxiety and fear. The infection protection procedures for COVID-19 are highly complex and medical staff need to constantly change clothes and replace protective equipment, so they are more likely to establish obsessive-compulsive behaviors. Medical personnel, especially young medical staff, have less experience in the field and in dealing with difficulties and hardships in life. Therefore, when they suddenly encounter such sudden public...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 81, "answer": "The infection protection procedures for COVID-19 are highly complex and medical staff need to constantly change clothes and replace protective equipment, so they are more likely to establish obsessive-compulsive behaviors."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...infectious disease outbreaks and provide more advancedmental health care for COVID-19 pneumonia. In terms of the mental health care response to the COV-ID-19 outbreak in China, Xiang et al. 8 suggested three important factors: 1) multidisciplinary mental health teams (psychiatrists, psychiatric nurses, clinical psychologists, and other mental health professionals), 2) clear communication with regular and accurate updates about the COVID-19 outbreak, and 3) establishment of secure services to provide psychological counseling (e.g., electronic devices and applications). These suggestions by Xiang et al. 8 could be a good reference for providing mental health care in response to the COVID-19 outbreak in Korea. Furthermore, following the 2014...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 82, "answer": "8 suggested three important factors: 1) multidisciplinary mental health teams (psychiatrists, psychiatric nurses, clinical psychologists, and other mental health professionals), 2) clear communication with regular and accurate updates about the COVID-19 outbreak, and 3) establishment of secure services to provide psychological counseling (e.g., electronic devices and applications)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...in various culture settings with SARS, 4, 5, 6 pandemic influenza A(H1N1), 7, 8, 9, 10 and influenza A(H7N9). 11, 12, 13 Cultural differences are evident in public responses. 14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings. 4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons. First, government engagement in the control of the outbreak...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 83, "answer": "14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The strongest predictor of behavioral change was perceived severity (1.2, 1.1-1.4) , followed by confusion about information reliability (1.1, 1.0-1.3). Conclusions: Psychological and behavioral responses to COVID-19 have been dramatic during the rising phase of the outbreak. Our results support efforts for timely dissemination of accurate and reliable information to address the high anxiety level. All rights reserved. No reuse allowed without permission. the author/funder, who...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 84, "answer": "Conclusions: Psychological and behavioral responses to COVID-19 have been dramatic during the rising phase of the outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The ongoing COVID-19 outbreak has expanded rapidly throughout China. Major behavioral, clinical, and state interventions are underway currently to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, have affected COVID-19 spread in China. We use real-time mobility data from Wuhan and detailed case data including travel...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 85, "answer": "Major behavioral, clinical, and state interventions are underway currently to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Importantly, ours is another study in which taking the mobility patterns into account in as realistic as possible way emerges as a key factor for modeling purposes. In this sense, our conclusions point out that despite the many advances in disease modeling during the last two decades, there still remain many open challenges, most of them related to how to sensibly incorporate human behavioral changes and response to the COVID-19 outbreak. We implement a stochastic SEIR-metapopulation model to simulate the spread of the epidemic across mainland China. The model can be divided in two discrete processes: the disease dynamics governed...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 86, "answer": "In this sense, our conclusions point out that despite the many advances in disease modeling during the last two decades, there still remain many open challenges, most of them related to how to sensibly incorporate human behavioral changes and response to the COVID-19 outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...(COVID-19) It was found that the sensitivity was greatly influenced by viral shedding and was dependent on the date of sample collection with respect to illness onset [13] . These factors also reduce the previously mentioned ascertainment rate for COVID-19 and indicate that the estimate is likely less than 9.2%. Therefore, the actual number of total cases infected with SARS-CoV-2 causing COVID-19 is likely to be more than 11-fold the number of observed cases as of 16 February 2020....", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 87, "answer": "These factors also reduce the previously mentioned ascertainment rate for COVID-19 and indicate that the estimate is likely less than 9.2%."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...41 42 Discussion: Risk perception towards COVID-19 in the community was high. Most respondents are alert 43 to the disease progression, and adopt self-protective measures. This study contributes by examining the 44 psycho-behavioral responses of hosts, in addition to the largely studied mechanistic aspects, during the 45 early phase of the current COVID-19 epidemic. The timely psychological and behavioral assessment of 46 the community is useful to inform subsequent interventions and risk communication strategies as the 47 epidemic progresses....", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 88, "answer": "This study contributes by examining the 44 psycho-behavioral responses of hosts, in addition to the largely studied mechanistic aspects, during the 45 early phase of the current COVID-19 epidemic."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The diagnosis of COVID-19 relies on the following criteria: clinical symptoms, epidemiological history and positive CT images, as well as positive pathogenic testing. The clinical characteristics of COVID-19 include respiratory symptoms, fever, cough, dyspna, and pneumonia [2] [3] [4] [5] . However, these symptoms are nonspecific, as there are isolated cases where, for example, in an asymptomatic infected family a chest CT scan revealed pneumonia and the pathogenic test for...", "qas": [{"question": "What are behavioral factors for COVID-19?", "id": 89, "answer": "The clinical characteristics of COVID-19 include respiratory symptoms, fever, cough, dyspna, and pneumonia [2] [3] [4] [5] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings. 4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons. First, government engagement in the control of the outbreak has been unprecedented, for example, locking down Wuhan and surrounding cities, building new hospitals to treat infected patients in Wuhan...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 90, "answer": "4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...in various culture settings with SARS, 4, 5, 6 pandemic influenza A(H1N1), 7, 8, 9, 10 and influenza A(H7N9). 11, 12, 13 Cultural differences are evident in public responses. 14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings. 4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons. First, government engagement in the control of the outbreak...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 91, "answer": "14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The strongest predictor of behavioral change was perceived severity (1.2, 1.1-1.4) , followed by confusion about information reliability (1.1, 1.0-1.3). Conclusions: Psychological and behavioral responses to COVID-19 have been dramatic during the rising phase of the outbreak. Our results support efforts for timely dissemination of accurate and reliable information to address the high anxiety level. All rights reserved. No reuse allowed without permission. the author/funder, who...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 92, "answer": "Conclusions: Psychological and behavioral responses to COVID-19 have been dramatic during the rising phase of the outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...COVID-19 With the current severe outbreak of coronavirus disease emerging from Wuhan in China in late 2019, several countries worldwide battle to control the spread of this devastating virus. The ongoing outbreak is accompanied by many human casualties and significant socio-economic losses globally and has now reached the proportions of a pandemic, with more than 81,000 COVID-19 confirmed cases and more than 2,760 related fatalities worldwide (February 26, 2020) . Unfortunately, CoV-specific FDA-approved drugs are still not available in the clinics. In this study, to address the urgent unmet medical needs and to facilitate the development or identification of...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 93, "answer": "The ongoing outbreak is accompanied by many human casualties and significant socio-economic losses globally and has now reached the proportions of a pandemic, with more than 81,000 COVID-19 confirmed cases and more than 2,760 related fatalities worldwide (February 26, 2020) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...[19] [20] [21] The implementation of these NPIs has coincided with the rapid decline in the number of new cases across China, albeit at high economic and social costs. 15, 16 On February 17, the State Council required localities to formulate differentiated county-level measures for precise containment of the COVID-19 outbreak and the restoration of socioeconomy affected by the outbreak. 22 The timing of implementing and lifting interventions is likely to have been and continue to be important, to take advantage of the window of opportunity to save lives...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 94, "answer": "15, 16 On February 17, the State Council required localities to formulate differentiated county-level measures for precise containment of the COVID-19 outbreak and the restoration of socioeconomy affected by the outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Importantly, ours is another study in which taking the mobility patterns into account in as realistic as possible way emerges as a key factor for modeling purposes. In this sense, our conclusions point out that despite the many advances in disease modeling during the last two decades, there still remain many open challenges, most of them related to how to sensibly incorporate human behavioral changes and response to the COVID-19 outbreak. We implement a stochastic SEIR-metapopulation model to simulate the spread of the epidemic across mainland China. The model can be divided in two discrete processes: the disease dynamics governed...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 95, "answer": "In this sense, our conclusions point out that despite the many advances in disease modeling during the last two decades, there still remain many open challenges, most of them related to how to sensibly incorporate human behavioral changes and response to the COVID-19 outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Only 16% respondents found official websites reliable. Enhanced personal 36 hygiene practices and travel avoidance to China were frequently adopted (>77%) and considered 37 effective (>90%). The adoption of social-distancing measures was lower (39%-88%), and their drivers 38 for greater adoption include: being female (adjusted odds ratio [aOR]:1.27), living in the New 39 Territories (aOR:1.32-1.55), perceived as having good understanding of COVID-19 (aOR:1.84) and 40 being more anxious (aOR:1.07). 41 42 Discussion: Risk perception towards COVID-19 in the community was high. Most respondents are alert 43 to the disease progression, and adopt self-protective measures....", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 96, "answer": "The adoption of social-distancing measures was lower (39%-88%), and their drivers 38 for greater adoption include: being female (adjusted odds ratio [aOR]:1.27), living in the New 39 Territories (aOR:1.32-1.55), perceived as having good understanding of COVID-19 (aOR:1.84) and 40 being more anxious (aOR:1.07)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...a significant factor in the success of many of these mechanisms-particularly given the significant percentage of TCMs that are over-the-counter products (access to which is not mediated by practitioners). The factors influencing consumer behavior are highly complex and include consumption need and motivations, perceptions, behavioral learning, attitudes, and socio-cultural factors [19] [20] . Therefore, while it has been argued that social marketing strategies can serve as powerful tools for publicity and education [10] [11] [12] 20 ] that can change the preferences...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 97, "answer": "The factors influencing consumer behavior are highly complex and include consumption need and motivations, perceptions, behavioral learning, attitudes, and socio-cultural factors [19] [20] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...cases have been diagnosed in China, including 2239 deaths 5 . Despite the rapid spread over the world, the clinical features and laboratory inspection of COVID-19 keep largely unclear. The clinical characteristics of severe COVID-19 cases were similar to severe acute respiratory syndrome ( SARS ) and the Middle East Respiratory Syndrome ( MERS ) that could occur acute respiratory distress syndrome (ARDS), acute cardiac injury, and even death 6 .Whereas the main clinical features of COVID-19 patients are fever, cough and sore throat. However, there are few reports on the clinical features and laboratory detection results of NCP cases in every regions of Hubei province outside Wuhan....", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 98, "answer": "The clinical characteristics of severe COVID-19 cases were similar to severe acute respiratory syndrome ( SARS ) and the Middle East Respiratory Syndrome ( MERS ) that could occur acute respiratory distress syndrome (ARDS), acute cardiac injury, and even death 6 .Whereas the main clinical features of COVID-19 patients are fever, cough and sore throat."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...in all other provinces is the robust sub-exponential rise in the number of confirmed cases according to the scaling law t \u00b5 during the first episode of the epidemic. This general, almost universal behavior is evidence that fundamental principles are at work associated with this particular epidemic that are dominated by the interplay of the contagion process with endogeneous behavioral changes in the susceptible population and external mitigation policies. We find that the generic scaling of case counts with time is independent of many other factors that often shape the time-course of an epidemic. The model defined by...", "qas": [{"question": "What are the differences of Socio-economic and behavioral factors for COVID-19?", "id": 99, "answer": "This general, almost universal behavior is evidence that fundamental principles are at work associated with this particular epidemic that are dominated by the interplay of the contagion process with endogeneous behavioral changes in the susceptible population and external mitigation policies."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...to be isolated and are still in the R class. The disease transmission flow chart is depicted in Figure 1 and other parameters are summarized in Table 2 . Based on the above assumptions, we formulate the following model to describe the transmission dynamics of COVID-19. \u27e8 Figure 1 is near here \u27e9 According to the concept of next generation matrix in [20] and the basic reproduction number presented in [21] , we calculate the...", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 100, "answer": "Based on the above assumptions, we formulate the following model to describe the transmission dynamics of COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...For example, with one command, users can easily plot the distribution of cases on the maps of the world, China, and even individual provinces ( Figure 1 ). With historical data, we can incorporate temporal and spatial information to create an animation to help us understand disease transmission and examine the spread of the COVID-19 outbreak. To enable users to access these datasets without coding, we also developed interactive web apps in both English [9] and Chinese [10] . As demonstrated in Supp....", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 101, "answer": "With historical data, we can incorporate temporal and spatial information to create an animation to help us understand disease transmission and examine the spread of the COVID-19 outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...to estimate transmission dynamics within a relatively closed system, where immediate public health responses were implemented, contacts were identified and quarantined, and key infection dates were tracked and published. We use these clusters to estimate both incubation period and serial interval for COVID-19, in both datasets, and discuss the implications of our findings for R0 estimates and pre-symptomatic transmission. All datasets and R code are available on GitHub (github.com/carolinecolijn/ClustersCOVID19). Singapore data was obtained from the Ministry of Health Singapore [14] online press releases....", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 102, "answer": "We use these clusters to estimate both incubation period and serial interval for COVID-19, in both datasets, and discuss the implications of our findings for R0 estimates and pre-symptomatic transmission."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...there was likely substantial variation in SARS-CoV-2 transmission over time, and suggest a decline in transmission in Wuhan in late January around the time that control measures were introduced. If COVID-19 transmission establishes outside of Wuhan, understanding the effectiveness of control measures in different settings will be crucial for understanding the likely dynamics of the outbreak, and the likelihood that transmission can eventually be contained. interpreted the findings, contributed to writing the manuscript and approved the final version for submission. Figure 1 : Model structure. The population is divided into four classes: susceptible, exposed...", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 103, "answer": "If COVID-19 transmission establishes outside of Wuhan, understanding the effectiveness of control measures in different settings will be crucial for understanding the likely dynamics of the outbreak, and the likelihood that transmission can eventually be contained."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of all secondary infections should be prevented to control spread. quarantined and sections of the Baodi District where the store is located were sealed and put under security patrol. We screened publicly available data to identify datasets for two COVID-19 clusters that can be used to estimate transmission dynamics within a relatively closed system, where immediate public health responses were implemented, contacts were identified and quarantined, and key infection dates were tracked and published. We use these clusters to estimate both incubation period and serial interval for COVID-19, in both datasets, and discuss the implications of our findings for R0 estimates and pre-symptomatic...", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 104, "answer": "We screened publicly available data to identify datasets for two COVID-19 clusters that can be used to estimate transmission dynamics within a relatively closed system, where immediate public health responses were implemented, contacts were identified and quarantined, and key infection dates were tracked and published."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) assay or high-throughput sequencing of nasal and pharyngeal swab specimens. We only included laboratory-confirmed cases in our analyses for consistency of case definition throughout the periods. To better reflect the dynamics of the Covid-19 epidemic and corresponding interventions, we classified the outbreak into four periods based on important dates that could affect the virus transmission (Fig. The time before January 11, 2020, the first date of Chunyun (massive migration for the Chinese New Year), was considered as the first period when no intervention was imposed....", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 105, "answer": "To better reflect the dynamics of the Covid-19 epidemic and corresponding interventions, we classified the outbreak into four periods based on important dates that could affect the virus transmission (Fig."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...during this outbreak and are sometimes referred to as quarantines, here we focus on the effectiveness of quarantine and active monitoring on an individual basis based on contact tracing. We built upon a previously published approach 6 using recent estimates of transmission dynamics for COVID-19 to account for critical questions and parameter uncertainties. Reflecting the uncertainty surrounding key parameters for COVID-19, we compared two sets of serial interval parameters: 1) from Nishiura et al 11 with a mean serial interval of 4.8...", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 106, "answer": "We built upon a previously published approach 6 using recent estimates of transmission dynamics for COVID-19 to account for critical questions and parameter uncertainties."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...that in all the analyzed areas (8 out of 9 most affected provinces outside Hubei and one additional location), Rt was below the epidemic threshold as of February 8. We have provided an assessment of the rapidly changing epidemiology and transmission dynamics of the COVID-19 outbreak beyond Hubei Province in mainland China. We found significant differences in the epidemiology of COVID-19 as the epidemic continues to spread across China. Most importantly, as of February 8, 2020, we estimate the net reproduction...", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 107, "answer": "We have provided an assessment of the rapidly changing epidemiology and transmission dynamics of the COVID-19 outbreak beyond Hubei Province in mainland China."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...not added in our study, and we also did not district the age distribution in our model. The study has numerically estimated the efficacy of traffic blockage and quarantine. We confirm by simulated quantification evidence that the traffic blockage is effective in controlling the epidemic of COVID-19, and the quarantine is a more effective way to help the public to prevent cross-infection. With the development of the epidemic, we have to admit the fact that there are still a number of population who are exposed to the COVID-19 without clinical symptoms...", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 108, "answer": "We confirm by simulated quantification evidence that the traffic blockage is effective in controlling the epidemic of COVID-19, and the quarantine is a more effective way to help the public to prevent cross-infection."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...data obtained during health emergencies is the potential lack of information from locations overwhelmed by the outbreak (in this case, Hubei province and other provinces with weaker health infrastructures). Future studies based on larger samples of patients with COVID-19 could explore in more detail the transmission dynamics of the outbreak in different locations, the effectiveness of interventions, and the demographic factors driving transmission. For an example of an online source see https://ncov.dxy.cn/ ncovh5/view/pneumonia information on patients reported in China, we also compiled additional information on internationally exported cases of COVID-19....", "qas": [{"question": "What do we know about the transmission dynamics of the COVID-19?", "id": 109, "answer": "Future studies based on larger samples of patients with COVID-19 could explore in more detail the transmission dynamics of the outbreak in different locations, the effectiveness of interventions, and the demographic factors driving transmission."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...With more clinical reports published, the case numbers were adjusted based on the information presented, which gave a more accurate transmission estimation. The basic reproductive number for COVID-19 was then found to be 5.6, which is substantially higher than that for SARS. In an enclosed and crowded environment, the transmission of SARS-CoV-2 was thought to significantly increase. The Diamond Princess Cruise provided an excellent case study as the development of COVID-19...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 110, "answer": "The basic reproductive number for COVID-19 was then found to be 5.6, which is substantially higher than that for SARS."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...20, 2020, when human-to-human transmission of COVID-19 was officially confirmed, people had not realized the infection of the epidemic and the SARS-CoV-2 was in a state of natural transmission. By estimating the trend in the early stages of the epidemic, combining equation (3.3), the basic reproductive numbers R 0 of COVID-19 is 3.56 (95% CI: 2.31 -4.81). We define the peak value as the peak of I(t), which is the cumulative number of infected cases. After this peak point, the temporary number of cases gradually decrease...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 111, "answer": "By estimating the trend in the early stages of the epidemic, combining equation (3.3), the basic reproductive numbers R 0 of COVID-19 is 3.56 (95% CI: 2.31 -4.81)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.21.20026070 doi: medRxiv preprint estimated by CCDC (Chinese Center for Disease Control and Prevention) (3) . Meanwhile, the basic reproductive number R 0 of COVID-19 was estimated between 3.25 and 3.4, larger than that of SARS. Paralleled results based on other models could be found in (1, 5, (10) (11) (12) (13) (14) . In this study, by data fitting, we are able to predict...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 112, "answer": "Meanwhile, the basic reproductive number R 0 of COVID-19 was estimated between 3.25 and 3.4, larger than that of SARS."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...may lead to misinterpretations, especially for what concerns the real weight that R0 has on the spreading of an infectious disease and on the feasibility of controlling an epidemic. 6 The basic reproductive number (R0) of COVID-19 has been initially estimated by the World Health Organization (WHO) to range between 1.4 and 2.5, as declared in the statement regarding the outbreak of SARS-CoV-2, dated 23th January 2020. 7 However, several published studies aimed to precisely estimate the COVID-19 R0. A recent review written by Liu et al. compared 12 studies published from the 1st of January...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 113, "answer": "6 The basic reproductive number (R0) of COVID-19 has been initially estimated by the World Health Organization (WHO) to range between 1.4 and 2.5, as declared in the statement regarding the outbreak of SARS-CoV-2, dated 23th January 2020."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...the basic reproduction number, denoted as \" , which measures the number of secondary cases that can be expected to be generated from a single case of the disease. 6 Initial research from the first weeks of the COVID-19 outbreak estimated the basic reproduction number to be between 2.20 and 3.58, indicating large uncertainty in estimates of its infectiousness. 7, 8 Other unpublished estimates also placed the value of \" within this range, 9 with wide uncertainty. 5 All of these estimates of the basic reproduction number were...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 114, "answer": "6 Initial research from the first weeks of the COVID-19 outbreak estimated the basic reproduction number to be between 2.20 and 3.58, indicating large uncertainty in estimates of its infectiousness."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...earliest stage because of the possibility of asymptomatic infections (7) . On the other hand, new models on the quantitative analysis of the spread of epidemic have been developed. For instance, (8) adopted a novel statistical time delay dynamic system to estimate the basic reproductive number R 0 of COVID-19 based on Wallinga and Lipsitch's framework (9) with distribution of the generation interval of the infection obtained. In (8) , the growth rate of COVID-19 was estimated to be between 0.30 and 0.32, higher than that 4 All rights reserved. No reuse allowed without permission. author/funder,...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 115, "answer": "For instance, (8) adopted a novel statistical time delay dynamic system to estimate the basic reproductive number R 0 of COVID-19 based on Wallinga and Lipsitch's framework (9) with distribution of the generation interval of the infection obtained."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "..., we assumed that number of secondary cases associated with a primary COVID-19 case follows a negative binomial (NB) distribution, with means R0 and dispersion parameter k [3] . Here, the R0 is the basic reproduction number of COVID-19. The k measures the likelihood of occurrence of super-spreading events (or other factors) which could vary the growth rate. If k is smaller than 1, these data indicate occurrence...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 116, "answer": "Here, the R0 is the basic reproduction number of COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...copyright holder for this preprint . https: //doi.org/10.1101 //doi.org/10. /2020 COVID-19 is spreading at a much higher rate and at a larger scale compared to the 2003 SARS epidemic. The basic reproductive number, R0, for SARS was determined to be 3 with 95% CI being 2 to 4 (Dye and Gay, 2003) . However, contrary to public knowledge, the earlier reports from the COVID-19 outbreak provided a R0 number less than or equal to that for SARS Wu et al., 2020; Zhou...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 117, "answer": "The basic reproductive number, R0, for SARS was determined to be 3 with 95% CI being 2 to 4 (Dye and Gay, 2003) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...the control measures were implemented. The last few cases were family members of confirmed patients, which were hard to prevent when living in a home with an infected individual. Studies indicate the basic reproductive number of COVID-19 was estimated to be 2.2 (95% CI, 1.4 to 3.9). The epidemic doubled in size every 7.4 days without control measures. 22 If measures were not taken in time, the consequences would be unimaginable. To date, some close contacts...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 118, "answer": "Studies indicate the basic reproductive number of COVID-19 was estimated to be 2.2 (95% CI, 1.4 to 3.9)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...China and other countries and has caused more than 2,000 deaths. As the disease continues to spread, the biomedical society urgently began identifying effective approaches to prevent further outbreaks. Through rigorous epidemiological analysis, we characterized the fast transmission of COVID-19 with a basic reproductive number 5.6 and proved a sole zoonotic source to originate in Wuhan. No changes in transmission have been noted across generations. By evaluating different control strategies through predictive modeling and Monte carlo simulations, a comprehensive quarantine in hospitals and quarantine stations...", "qas": [{"question": "What is the basic reproductive number of COVID-19?", "id": 119, "answer": "Through rigorous epidemiological analysis, we characterized the fast transmission of COVID-19 with a basic reproductive number 5.6 and proved a sole zoonotic source to originate in Wuhan."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Generally, incubation period can be measured by physiological observations and biological experiments [33] . The determination of incubation period has great implications for disease transmission control and policy making. The estimation of the incubation period of COVID-19 is a very difficult task. The main difficulty is in that it is difficult to determine the infected time. Based on patients' information, some works have reported the incubation period of COVID-19....", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 120, "answer": "The estimation of the incubation period of COVID-19 is a very difficult task."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The earliest patients in Wuhan are related to exposure from a seafood market. Later, the number of patients grows drastically due to human-to-human transmission [3] . The incubation period of COVID-19 is reported to be 3-7 days, at most 14 days, which varies greatly among patients [2] . The novel coronavirus is believed to be infectious during incubation period when no symptoms are shown on the patients [4] , an important characteristics differentiating COVID-19 from its close...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 121, "answer": "The incubation period of COVID-19 is reported to be 3-7 days, at most 14 days, which varies greatly among patients [2] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of their epidemiological history, signs, symptoms and chest CT evidence according to National Health Commission of the People's Republic of China guidance, though they tested negative for the SARS-CoV-2. 13,14 The incubation period was defined as the time from the exposure to the confirmed or suspected transmission source to the onset of illness. A team of doctors who had been treating these patients extracted the medical records of these patients and sent the data to working group in Ningbo to further examine....", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 122, "answer": "13,14 The incubation period was defined as the time from the exposure to the confirmed or suspected transmission source to the onset of illness."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of COVID-19 infection, as these migration events limit the risk of infection to the time during which an individual traveled to an area where exposure could occur [4] . The incubation period is defined as the time from infection to illness onset. Knowledge of the incubation period of a directly transmitted infectious disease is critical to determine the time period required for monitoring and restricting the movement of healthy individuals (i.e.,...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 123, "answer": "The incubation period is defined as the time from infection to illness onset."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The maximum-likelihood estimates for the parametric distribution of the cumulative distribution function are shown, along with 1000 parametric bootstrap estimates of the cumulative distribution function. We estimate the median incubation period of COVID-19 is 4.8 days (95%CI, 4.2, 5.4). 5% of the cases who develop symptoms will do so by 1.6 days (95% CI, 1.3, 2.0) after infection, and 95% by 14.0 days (12.2, 15.9) . We estimated...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 124, "answer": "We estimate the median incubation period of COVID-19 is 4.8 days (95%CI, 4.2, 5.4)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...transmission during the incubation period in 50 infection clusters, including 124 cases. All the secondary cases had a history of contact with their first-generation cases prior to symptom onset. The estimated mean incubation period for COVID-19 was 4.9 days (95% confidence interval [CI], 4.4 to 5.4) days, ranging from 0.8 to 11.1 days (2.5th to 97.5th percentile). The observed mean and standard deviation (SD) of serial interval was 4.1\u00b13.3 days, with the 2.5th and 97.5th percentiles at -1 and 13 days. The infectious curve showed that...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 125, "answer": "The estimated mean incubation period for COVID-19 was 4.9 days (95% confidence interval [CI], 4.4 to 5.4) days, ranging from 0.8 to 11.1 days (2.5th to 97.5th percentile)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...overview It is very likely that person-to-person transmissions occur via droplets and contact. Nosocomial infections in the healthcare facilities did happen and stress the importance of good infection control. COVID-19 has a mean incubation period of 5.2 days (95% confidence interval, 4.1-7.0). 16 The infection is acute without any carrier status. Symptoms usually begin with nonspecific syndromes, including fever, dry cough, and fatigue. Multiple systems may be involved, including respiratory (cough,...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 126, "answer": "COVID-19 has a mean incubation period of 5.2 days (95% confidence interval, 4.1-7.0)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The present study advances the public discussion on COVID-19 infections by presenting explicit estimations of the incubation period and other epidemiologic characteristics using publicly available data. Our estimated mean incubation period of approximately 5 days is comparable to known mean values of the incubation period for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) [9, [16] [17] [18] , as well as other recent estimates of the incubation period for COVID-19 [18] . In addition to empirically showing the comparability of COVID-19 to other disease-causing coronaviruses, the present study has also shown that the 95th percentile of the incubation period is around...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 127, "answer": "Our estimated mean incubation period of approximately 5 days is comparable to known mean values of the incubation period for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) [9, [16] [17] [18] , as well as other recent estimates of the incubation period for COVID-19 [18] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...is in that it is difficult to determine the infected time. Based on patients' information, some works have reported the incubation period of COVID-19. For example, Yang et al. [4] reported that the median incubation period of COVID-19 is 4.75 days; the interquartile range is 3.0 \u2212 7.2 days. Hereinafter, we try to estimate the incubation period of patients in Henan. The collected data are with varied quality, many descriptions of patients only told us when the person...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 128, "answer": "[4] reported that the median incubation period of COVID-19 is 4.75 days; the interquartile range is 3.0 \u2212 7.2 days."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in...", "qas": [{"question": "What is the incubation period of COVID-19?", "id": 129, "answer": "The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Serial interval of novel coronavirus (COVID-19) infections We scanned publicly available information published in research articles and quoted from official reports of outbreak investigations to obtain our dataset. The date of illness onset was defined as the date on which a symptom relevant to COVID-19 infection appeared and was determined by the reporting governmental body. We subjectively ranked the credibility of the ascertained pairs into \"certain\" and \"probable,\" where the former was used for pairs and dates of illness onset were clearly defined in...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 130, "answer": "The date of illness onset was defined as the date on which a symptom relevant to COVID-19 infection appeared and was determined by the reporting governmental body."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...window T, and sizes of the catchment population of the Wuhan International airport n. The value of the basic reproduction number 0 for the COVID-19 epidemic was calculated as where r is the estimated growth rate for each scenario and S is the mean serial interval for successive COVID-19 infections. The value of the serial interval was adopted from a published study [2] , and a gamma distribution was fitted to six known pairs of the infectee and infector...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 131, "answer": "where r is the estimated growth rate for each scenario and S is the mean serial interval for successive COVID-19 infections."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...large impact of perfect isolation, if one assumed there was limited pre-symptomatic transmission and a high probability of tracing contacts to be put under isolation immediately following symptom onset. However, the estimates for the serial interval of COVID-19, which impacts the amount of pre-symptomatic transmission, are varied. As COVID-19 continues to spread, better understanding how to contain it becomes critical. Here, using methods we previously developed and the latest epidemiological parameters reported for COVID-19, we compare...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 132, "answer": "However, the estimates for the serial interval of COVID-19, which impacts the amount of pre-symptomatic transmission, are varied."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...on the Diamond Princess cruise ship: A data-driven analysis Serial interval distribution is required for R0 estimation, and there was insufficient information about cluster cases for serial interval estimation. Therefore, we assumed the serial interval of COVID-19 on the ship was equal to that of COVID-19 in Wuhan, China, with a mean of 7.5 days and a standard deviation of 3.4 days . We fitted the value of serial interval (mean and standard deviation) with a gamma distribution, as previously described . The \"get_R\" function with Maximum-Likelihood (ML) estimation was used to...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 133, "answer": "Therefore, we assumed the serial interval of COVID-19 on the ship was equal to that of COVID-19 in Wuhan, China, with a mean of 7.5 days and a standard deviation of 3.4 days ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...could incorporate data augmentation techniques that may be able to produce historical time series with likely estimates of case counts based on onset of disease rather than reporting dates. This, along with more detailed estimates of the serial interval distribution, could yield more realistic estimates of R. Finally, further experimental work needs to be conducted to better understand the mechanisms of transmission of the COVID-19. Mechanistic understanding of transmission could lead to a coherent justification of our findings. Sustained transmission and rapid (exponential) growth of cases are possible over a range of humidity conditions...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 134, "answer": "This, along with more detailed estimates of the serial interval distribution, could yield more realistic estimates of R. Finally, further experimental work needs to be conducted to better understand the mechanisms of transmission of the COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...We assume that the distribution is Gamma distribution, i.e., the corresponding probability density function is where the parameters are n = 5 and b = 2 3 . So the mean of the distribution is n b = 7.5 which is exactly equal to the number announced in [9] , where they claimed that the mean serial interval of COVID-19 is 7.5 days (95% CI, 5.3 to 19). Besides the mean, comparison of (1.1) with Fig2B is more convince. The formula is so beautiful, that we believe it must be true. The other distributions are also given...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 135, "answer": "So the mean of the distribution is n b = 7.5 which is exactly equal to the number announced in [9] , where they claimed that the mean serial interval of COVID-19 is 7.5 days (95% CI, 5.3 to 19)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Estimating key infectious disease parameters from the COVID-19 outbreak is quintessential for modelling studies and guiding intervention strategies. Whereas different estimates for the incubation period distribution and the serial interval distribution have been reported, estimates of the generation interval for COVID-19 have not been provided. Methods: We used outbreak data from clusters in Singapore and Tianjin, China to estimate the generation interval from symptom onset data while acknowledging uncertainty about the incubation period distribution...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 136, "answer": "Whereas different estimates for the incubation period distribution and the serial interval distribution have been reported, estimates of the generation interval for COVID-19 have not been provided."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...the portion of transmission events that occur before symptom onset is a central quantity for infection control [25] . In Singapore and Tianjin we estimated relatively short serial intervals. Of particular note, early estimates of R0 for COVID-19 used the SARS serial interval of 8.4 days [7, 8, 26] . Our serial interval findings from two populations mirror those of and Zhao et al [27] and Nishiura et al [13] , who estimated a serial interval of 4.4 and...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 137, "answer": "Of particular note, early estimates of R0 for COVID-19 used the SARS serial interval of 8.4 days [7, 8, 26] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...serial interval of COVID-19 is close to or shorter than its median incubation period. This suggests that a substantial proportion of secondary transmission may occur prior to illness onset. The COVID-19 serial interval is also shorter than the serial interval of severe acute respiratory syndrome (SARS), indicating that calculations made using the SARS serial interval may introduce bias. J o u r n a l P r e -p r o o f -3 -If the transmission takes place during the symptomatic period of the primary case,...", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 138, "answer": "The COVID-19 serial interval is also shorter than the serial interval of severe acute respiratory syndrome (SARS), indicating that calculations made using the SARS serial interval may introduce bias."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...cases are from age 15 or less , while in China, 0-14 years are 17.2%. To take this effect into account, we assume 10% of the population are 'protected'. Recent studies showed the serial interval of COVID-19 could be as short as 5 days (Nishiura et al., 2020a) , and the median incubation period could be as short as 4 days . These characteristics imply short latent period and infectious period. Thus, we adopt a relatively shorter mean latent period (3 days) and mean infectious period (4 days)....", "qas": [{"question": "What is the serial interval  of COVID-19?", "id": 139, "answer": "Recent studies showed the serial interval of COVID-19 could be as short as 5 days (Nishiura et al., 2020a) , and the median incubation period could be as short as 4 days ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...contributed to extra-pulmonary manifestations in a number of patients at the onset of the illness, such as headache, diarrhoea, nausea and vomiting, 4 or even presented with asymptomatic infection. 8 Despite the intensive work that has been focused on an understanding of the transmission of SARS-CoV-2, the spread mode of the SARS-CoV-2 is unclear. To our knowledge, limited investigations have been conducted to date into the clinical features of SARS-COV-2 in ocular surface. A few of COVID-19 patients with conjunctivitis, or even as...", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 140, "answer": "8 Despite the intensive work that has been focused on an understanding of the transmission of SARS-CoV-2, the spread mode of the SARS-CoV-2 is unclear."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...To minimize the risk of hospital-based transmission of SARS-CoV-2, the Ministry of Health of Singapore has restricted the movement of patients and staff across hospitals (20) . Also, because multiple unlinked community cases of COVID-19 have been reported (21) , various social distancing measures have been put in place including advising the public against large social gatherings in order to mitigate the risk of community transmission (22, 23) . These social distancing measures reduce the risk of onward transmission not only within Singapore, but also beyond the borders of this highly connected nation (24)....", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 141, "answer": "Also, because multiple unlinked community cases of COVID-19 have been reported (21) , various social distancing measures have been put in place including advising the public against large social gatherings in order to mitigate the risk of community transmission (22, 23) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...been underestimated, such as in humid and warmer locations. Our contribution. We examine variability in absolute humidity and transmission of COVID-19 across provinces in China and other select locations. We show that the observed patterns of COVID-19 are not completely consistent with the hypothesis that high absolute humidity may limit the survival and transmission of this new virus. Epidemiological data. To conduct our analysis, we collected epidemiological data from the Johns Hopkins Center for Systems Science and System website (6)....", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 142, "answer": "We show that the observed patterns of COVID-19 are not completely consistent with the hypothesis that high absolute humidity may limit the survival and transmission of this new virus."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...COVID-19 epidemic relies on case-based measures such as finding cases and tracing contacts. A variable that determines how effective these case-based measures are is the proportion of pre-symptomatic transmission. Our estimates of this proportion are high, ranging from 0.48 to 0.77. This implies that the effectiveness of case finding and contact tracing in preventing COVID-19 infections will be considerably smaller compared to the effectiveness in preventing SARS or MERS infections,...", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 143, "answer": "Our estimates of this proportion are high, ranging from 0.48 to 0.77."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...\"delayed cord clamping is not recommended\" in order to reduce the risk of vertical transmission and that infants should be separated from mothers affected by COVID 19 (22) . Infants may acquire COVID-19 from their mothers after delivery via normal routes of transmission. Guidance from China is that \"Infants should not be fed with the breast milk from mothers with confirmed or suspected of 2019-nCoV.\" Guidance from the CDC is less clear...", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 144, "answer": "Infants may acquire COVID-19 from their mothers after delivery via normal routes of transmission."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Her husband was also diagnosed with COVID-19, while they had no sexual behavior from 14 days before the first of symptoms to the day samples collected. The evidence so far suggests that respiratory droplets and intimate contact are the two main transmission routes of SARS-CoV-2 [19] [20] [21] [22] . Aerosol transmission also exists in relatively closed unventilated space 23 . Fecal-oral transmission is possible 23 . Vertical transmission have not been verified 16, 23 , although scientists have...", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 145, "answer": "The evidence so far suggests that respiratory droplets and intimate contact are the two main transmission routes of SARS-CoV-2 [19] [20] [21] [22] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...particular, cases arising from passengers without close contact indicate a possible pathway of infection via mechanisms that were not covered by the abovementioned analysis that relied on symptomatic cases. Although the transmission via direct human-to-human contact was prevented by movement restrictions, the role of other modes of transmission, e.g., environmental and asymptomatic transmissions, should be further explored. The author declares no conflict of interest....", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 146, "answer": "Although the transmission via direct human-to-human contact was prevented by movement restrictions, the role of other modes of transmission, e.g., environmental and asymptomatic transmissions, should be further explored."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...our study all had a history of recent travel to Wuhan or directly contact with NCP patients.This results was convincing proof that the disease is characterized by human-to-human transmission. A new study revealed that the reproductive number of COVID-19 is up to 3.28 [3] . However, in this study, the patients did not be acquired a clear transmission route, because the virus may have multiple transmission modes [12, 13] ....", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 147, "answer": "A new study revealed that the reproductive number of COVID-19 is up to 3.28 [3] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...not be obtained in time. Thus, careful interpretation is urged for this result. Up to now, no effective strategy has been found for treatment of COVID-19 infection [50] . Currently, the measure to COVID-19 is to control the source of the infection; taking personal protective works to reduce the risk of transmission; and early diagnosing, isolating and supportive treating for confirmed patients. In the present study, our systematic results of cure rate of drug for MERS-COV infection indicated that ribavirin and interferon, oseltamivir, antivirals and intravenous immunoglobulin all had been effective...", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 148, "answer": "Currently, the measure to COVID-19 is to control the source of the infection; taking personal protective works to reduce the risk of transmission; and early diagnosing, isolating and supportive treating for confirmed patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of cases and contacts 2 As people with the infection arrive in countries or areas without ongoing transmission, efforts are being made to halt transmission, and prevent potential outbreaks. 3, 4 Isolation of confirmed and suspected cases, and identification of contacts are a crucial part of these control efforts; however, whether these efforts will achieve control of transmission of COVID-19 is unclear. Isolation of cases and contact tracing becomes less effective if infectiousness begins before the onset of symptoms. 5, 6 For example, the severe acute respiratory syndrome (SARS) outbreak that...", "qas": [{"question": "What are the modes of transmission of COVID-19?", "id": 149, "answer": "3, 4 Isolation of confirmed and suspected cases, and identification of contacts are a crucial part of these control efforts; however, whether these efforts will achieve control of transmission of COVID-19 is unclear."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The diagnosis of COVID-19 relies on the following criteria: clinical symptoms, epidemiological history and positive CT images, as well as positive pathogenic testing. The clinical characteristics of COVID-19 include respiratory symptoms, fever, cough, dyspna, and pneumonia [2] [3] [4] [5] . However, these symptoms are nonspecific, as there are isolated cases where, for example, in an asymptomatic infected family a chest CT scan revealed pneumonia and the pathogenic test for...", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 150, "answer": "The clinical characteristics of COVID-19 include respiratory symptoms, fever, cough, dyspna, and pneumonia [2] [3] [4] [5] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...outbreak to support decision-making pertaining to disease control. Especially in locations where the risk of transmission may have been underestimated, such as in humid and warmer locations. Our contribution. We examine variability in absolute humidity and transmission of COVID-19 across provinces in China and other select locations. We show that the observed patterns of COVID-19 are not completely consistent with the hypothesis that high absolute humidity may limit the survival and transmission of this new virus....", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 151, "answer": "We examine variability in absolute humidity and transmission of COVID-19 across provinces in China and other select locations."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...attempting to estimate the R0 are complex and can be attributed to 3 possible reasons: i) different variables considered; ii) different methods for modeling; and iii) different estimation procedures. 9 Firstly, R0 is not an intrinsic variable of the infectious agent, but it is calculated through at least three parameters: the duration of contagiousness; the likelihood of infection per contact between; and the contact rate, along with economical, social and environmental factors, that may vary among studies aimed to estimate the R0. More, the use of different models for the estimation of R0 may play a role in the discrepancies observed among the studies on COVID-19. In fact, according to Liu's...", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 152, "answer": "9 Firstly, R0 is not an intrinsic variable of the infectious agent, but it is calculated through at least three parameters: the duration of contagiousness; the likelihood of infection per contact between; and the contact rate, along with economical, social and environmental factors, that may vary among studies aimed to estimate the R0."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...14, 15 Behavioral changes are also associated with government involvement level, perceptions of diseases, and the stage of the outbreak, and these factors vary by diseases and settings. 4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons. First, government engagement in the control of the outbreak has been unprecedented, for example, locking down Wuhan and surrounding cities, building new hospitals to treat infected patients in Wuhan...", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 153, "answer": "4, 5, 8, 16 The current COVID-19 outbreak provides a unique platform to study behavioral changes for two main reasons."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Comprehensive monitoring of hospital environmental hygiene during the 77 outbreak of the pandemic is conducive to the refinement of hospital infection control 78 [5, 7] . It also increases understanding of the environmental challenges corresponding to 79 the reemergence of COVID-19 or similar viruses. Therefore, it is of great significance 80 to ensure the safety of medical treatment and the quality of hospital infection control 81 through the monitoring of environmental hygiene....", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 154, "answer": "It also increases understanding of the environmental challenges corresponding to 79 the reemergence of COVID-19 or similar viruses."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...(COVID-19) It was found that the sensitivity was greatly influenced by viral shedding and was dependent on the date of sample collection with respect to illness onset [13] . These factors also reduce the previously mentioned ascertainment rate for COVID-19 and indicate that the estimate is likely less than 9.2%. Therefore, the actual number of total cases infected with SARS-CoV-2 causing COVID-19 is likely to be more than 11-fold the number of observed cases as of 16 February 2020....", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 155, "answer": "These factors also reduce the previously mentioned ascertainment rate for COVID-19 and indicate that the estimate is likely less than 9.2%."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...In order to identify the sta- Table 1 : Relationship between local exponential growth, log(R proxy ), and environmental factors (i.e., absolute humidity and temperature). tistical relevance of the relationship between the local reproductive number of COVID-19 cases and environmental factors, we fitted a linear model using the logarithm of the local reproductive number R proxy as our response variable. Absolute humidity and temperature were included as independent variables. Reproductive number proxy. Our estimates of R proxy , for each province within China and other countries appeared to be...", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 156, "answer": "tistical relevance of the relationship between the local reproductive number of COVID-19 cases and environmental factors, we fitted a linear model using the logarithm of the local reproductive number R proxy as our response variable."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...placed 70 unprecedented challenges on hospital environmental hygiene. The occurrence of 71 medical staff-associated infections is closely related to long-lived pathogens in the 72 hospital environment [4, 5] . Thus, it is crucial to assess hospital environmental hygiene 73 to understand the most important environmental issues for controlling the spread of 74 COVID-19 in hospitals. The Chinese government quickly adopted quarantine 75 measures for confirmed and suspected patients to restrain the spread of the 76 pandemic [6] . Comprehensive monitoring of hospital environmental hygiene...", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 157, "answer": "Thus, it is crucial to assess hospital environmental hygiene 73 to understand the most important environmental issues for controlling the spread of 74 COVID-19 in hospitals."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...connectivity between countries, international 123 mobility data is calculated from flight route numbers between airports. If more 124 direct routes are found between two airports, this represents higher connectivity. Assuming that all countries are fully committed to epidemic prevention and well-133 prepared for epidemic prevention but that there are no specific medicines or 134 vaccines, it is assumed that COVID-19 is not affected by climatic factors (such as 135 temperature). The changes in the case number for each country can be divided into 136 two major stages. The first stage is mainly based on imported cases of immigration 137...", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 158, "answer": "Assuming that all countries are fully committed to epidemic prevention and well-133 prepared for epidemic prevention but that there are no specific medicines or 134 vaccines, it is assumed that COVID-19 is not affected by climatic factors (such as 135 temperature)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...cases have been diagnosed in China, including 2239 deaths 5 . Despite the rapid spread over the world, the clinical features and laboratory inspection of COVID-19 keep largely unclear. The clinical characteristics of severe COVID-19 cases were similar to severe acute respiratory syndrome ( SARS ) and the Middle East Respiratory Syndrome ( MERS ) that could occur acute respiratory distress syndrome (ARDS), acute cardiac injury, and even death 6 .Whereas the main clinical features of COVID-19 patients are fever, cough and sore throat. However, there are few reports on the clinical features and laboratory detection results of NCP cases in every regions of Hubei province outside Wuhan....", "qas": [{"question": "What are the environmental factors of COVID-19?", "id": 159, "answer": "The clinical characteristics of severe COVID-19 cases were similar to severe acute respiratory syndrome ( SARS ) and the Middle East Respiratory Syndrome ( MERS ) that could occur acute respiratory distress syndrome (ARDS), acute cardiac injury, and even death 6 .Whereas the main clinical features of COVID-19 patients are fever, cough and sore throat."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...yet been fully addressed, although the global public health community is obliged to continually confront the epidemic and make political decisions encompassing travel restrictions, containment measures, and mitigation strategies. To accomplish the scientific assessment of the severity and sufficiently understand pitfalls surrounding the associated debates, we aim to guide the readers to understand the likely severity of COVID-19 and direct the course of future research. CFR is often measured by simply dividing the number of deaths from a disease by the number of cases of a disease as a function of time. If C...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 160, "answer": "To accomplish the scientific assessment of the severity and sufficiently understand pitfalls surrounding the associated debates, we aim to guide the readers to understand the likely severity of COVID-19 and direct the course of future research."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Importance: The recent outbreak of Novel Coronavirus (SARS-CoV-2) Disease has put the world on alert, that is reminiscent of the SARS outbreak seventeen years ago. Objective: We aim to compare the severity and mortality between male and female patients with both COVID-19 and SARS, to explore the most useful prognostic factors for individualized assessment. Design, Setting, and Participants: We extracted the data from a case series of 43 hospitalized patients we treated, a public data set of the first 37 cases died of...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 161, "answer": "Objective: We aim to compare the severity and mortality between male and female patients with both COVID-19 and SARS, to explore the most useful prognostic factors for individualized assessment."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...usual outbreak control measures including early identification and management of persons with infection, tracing of contacts with monitoring for onset of fever and/or symptoms, and active engagement of communities. Most modelling suggests that the severity of illness is more like influenza than SARS, and there is concern among the public health community because the transmissibility of COVID-19 is not yet fully understood, and the potential for it to become endemic like other respiratory pathogens is unknown. Because of the many unknowns, the initial reaction by health agencies is still valid: to brace for the first wave as the virus reaches a completely na\u00efve population and...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 162, "answer": "Most modelling suggests that the severity of illness is more like influenza than SARS, and there is concern among the public health community because the transmissibility of COVID-19 is not yet fully understood, and the potential for it to become endemic like other respiratory pathogens is unknown."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...tool by assigning values to each variable in the equation. Besides of that, we enrolled two more parameters into the final COVID-19 EWS, including age and meaningful respiratory symptoms. Based on the statistical analysis, we found that elderly people were more susceptible to COVID-19 and develop severe, which may due to their lower disease resistance and more basic diseases; some significant symptoms, such as cough, expectoration and dyspnea, can help to strengthen the association between fever and lower respiratory symptoms and weaken the weight of fever caused by other reasons. As a result, the COVID-19 EWS contained easy-to-get parameters on clinical manifestation, epidemiological characteristics, basic vital signs, laboratory and radiologic data, which provide a more comprehensive assessment of patients....", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 163, "answer": "Based on the statistical analysis, we found that elderly people were more susceptible to COVID-19 and develop severe, which may due to their lower disease resistance and more basic diseases; some significant symptoms, such as cough, expectoration and dyspnea, can help to strengthen the association between fever and lower respiratory symptoms and weaken the weight of fever caused by other reasons."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...For example, with one command, users can easily plot the distribution of cases on the maps of the world, China, and even individual provinces ( Figure 1 ). With historical data, we can incorporate temporal and spatial information to create an animation to help us understand disease transmission and examine the spread of the COVID-19 outbreak. To enable users to access these datasets without coding, we also developed interactive web apps in both English [9] and Chinese [10] . As demonstrated in Supp....", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 164, "answer": "With historical data, we can incorporate temporal and spatial information to create an animation to help us understand disease transmission and examine the spread of the COVID-19 outbreak."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...a single test with no delay), and our findings on symptom screening effectiveness over the course of infection are directly applicable to longitudinal screening in quarantine or occupational settings. The central aim of our analysis is to assess the expected effectiveness of screening for COVID-19, taking account of current knowledge and uncertainties about the natural history and epidemiology of the virus. We therefore show results using the best estimates currently available, in the hope of informing policy decisions in this fast-changing environment. We also make our model available for public...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 165, "answer": "The central aim of our analysis is to assess the expected effectiveness of screening for COVID-19, taking account of current knowledge and uncertainties about the natural history and epidemiology of the virus."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Other than the individual figures in the results, the final conclusion remains the same in terms of comparisons between genders, and among different age groups. We strongly believe that all the suspected cases represent real COVID-19 patients, as they met the criteria for clinical diagnosis. Furthermore, as described in Methods, the interpretation of nucleic acid test subsequently removed the suspect category. In conclusion, analysis of a cohort of 402 COVID-19 patients from a single...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 166, "answer": "We strongly believe that all the suspected cases represent real COVID-19 patients, as they met the criteria for clinical diagnosis."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...the best of our knowledge, the detailed mental health problems of the patients infected with COVID-19 pneumonia and healthcare workers treating the infected patients have not yet been reported. However, it is suggested that both confirmed and suspected COVID-19 patients may experience the fear of the consequences of this infection, including death and severe physical disability. Furthermore, boredom, loneliness, and anger could be experienced by individuals in quarantine. It is also suggested that anxiety symptoms and distress may be worsened not only by the infection...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 167, "answer": "However, it is suggested that both confirmed and suspected COVID-19 patients may experience the fear of the consequences of this infection, including death and severe physical disability."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of the disease, and thus reduce the mortality and save the socioeconomic resources. We also comprehensively describe the characteristics of severe (vs. mild) and death patients in our cohort. We noticed that severe patients had high frequencies of decreased lymphocytes, higher D-dimer, and lower albumin, suggesting that severe patients may had higher probability of immune deficiency, coagulation activation, and disease exhaustion condition. In addition, we also noticed abnormal ALT and creatinine levels in most patients who died, but most of the abnormalities were mild, suggesting that COVID-19 patients may die primarily...", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 168, "answer": "We noticed that severe patients had high frequencies of decreased lymphocytes, higher D-dimer, and lower albumin, suggesting that severe patients may had higher probability of immune deficiency, coagulation activation, and disease exhaustion condition."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Background: The current novel coronavirus outbreak, COVID-19, has spread to 28 countries and territories with tens of thousands infected and thousands of deaths (1) . Although risk of contracting the disease in the United States (US) is currently low (2) , it is important to understand risk perceptions about COVID-19 and trust in political and public health/scientific leadership among the US population to better inform messaging and policies (3) . Objective: In the first study of its kind on COVID-19, our objective was to survey the adult US population to better understand their risk perceptions about the COVID-19 outbreak....", "qas": [{"question": "What do we know about Severity of COVID-19?", "id": 169, "answer": "Although risk of contracting the disease in the United States (US) is currently low (2) , it is important to understand risk perceptions about COVID-19 and trust in political and public health/scientific leadership among the US population to better inform messaging and policies (3) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The transmission characteristics of COVID-19 appear to be similar to those of pandemic influenza and will likely facilitate further global spread [2] . During this early phase of a potential pandemic, it is critically important to obtain reliable estimates of the overall case fatality ratio (CFR), i.e., the proportion of all (asymptomatic and symptomatic) infected cases that will die as a result of the disease. Such estimates will help anticipate the expected morbidity and mortality due to COVID-19 and provide critical information for the planning of health care systems in countries that face an...", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 170, "answer": "During this early phase of a potential pandemic, it is critically important to obtain reliable estimates of the overall case fatality ratio (CFR), i.e., the proportion of all (asymptomatic and symptomatic) infected cases that will die as a result of the disease."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...fight against the novel coronavirus disease The clinical manifestation of COVID-19 is very complex, and four clinical phenotypes have been identified, i.e. mildly, commonly, severely, and critically ill patients. [7] Some cases are characterized by mild symptoms and close-to-normal body temperatures and some are asymptomatic carriers, but both symptomatic and asymptomatic patients are contagious, which leads to difficulties in the timely identification of cases. Attention should be paid to the spectrum of disease severity and transmission modes to address questions such as how to identify the proportion of asymptomatic infections and whether a...", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 171, "answer": "[7] Some cases are characterized by mild symptoms and close-to-normal body temperatures and some are asymptomatic carriers, but both symptomatic and asymptomatic patients are contagious, which leads to difficulties in the timely identification of cases."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...the estimated incidence in this study indicates that the movement restriction policy from 5 February 2020 was highly successful in greatly reducing the number of secondary transmissions on board. Based on an analysis of illness onset data on board (and before the disembarkation of a large number of passengers), the risk of infection among passengers without close contact was considered to be very limited Among disembarked passengers, symptomatic cases have started to be reported on the ground in and outside of Japan. In particular, cases arising from passengers without close contact indicate a possible pathway of infection via mechanisms that were not covered by the abovementioned analysis that relied on symptomatic...", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 172, "answer": "Based on an analysis of illness onset data on board (and before the disembarkation of a large number of passengers), the risk of infection among passengers without close contact was considered to be very limited Among disembarked passengers, symptomatic cases have started to be reported on the ground in and outside of Japan."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...There is large uncertainty around the case fatality risk (CFR) for COVID-19 in China. Therefore, we considered symptomatic cases outside of China (countries/settings with 20+ cases) and the proportion who are in intensive care units (4.0%, 14/349 on 13 February 2020)....", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 173, "answer": "There is large uncertainty around the case fatality risk (CFR) for COVID-19 in China."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...There is large uncertainty around the case fatality risk (CFR) for COVID-19 in China. Therefore, we considered symptomatic cases outside of China (countries/settings with 20+ cases) and the proportion who are in intensive care units (4.0%, 14/349 on 13 February 2020). Given what is known about CFRs for ICU patients with severe respiratory conditions from a meta-analysis, we estimated a CFR of 1.37% (95%CI: 0.57% to 3....", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 174, "answer": "Therefore, we considered symptomatic cases outside of China (countries/settings with 20+ cases) and the proportion who are in intensive care units (4.0%, 14/349 on 13 February 2020)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...infection, either by clinical detection of the pathogen or by seroconversion or other immune response. Such individuals may or may not be symptomatic, though asymptomatic ones may go undetected. The symptomatic case-fatality risk (sCFR) defines a case as someone who is infected and shows certain symptoms. Infection in many outbreaks is given several gradations, including confirmed (definitive laboratory confirmation), probable (high degree of suspicion, by various clinical and epidemiologic criteria, without laboratory confirmation), and possible...", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 175, "answer": "The symptomatic case-fatality risk (sCFR) defines a case as someone who is infected and shows certain symptoms."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...14th, the Chinese Center for Disease Control and Prevention (China CDC) published the first details of 44,672 confirmed cases, in the biggest study since the outbreak began [3] . Their findings show that COVID-19 was mild for 81% of patients and had an overall case fatality rate of 2.3%. Of those confirmed cases, only 2.2% were under 20 years old. Compared to adults, children generally present with much milder clinical symptoms. It is likely that future serological studies...", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 176, "answer": "Their findings show that COVID-19 was mild for 81% of patients and had an overall case fatality rate of 2.3%."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...nonspecific, whereas the detection of SARS-CoV-2 with a high viral load in the sputum of convalescent patients arouse concern about prolonged shedding of the virus after recovery [10] . In symptomatic COVID-19 patients, illness may evolve over the course of a week or longer, beginning with mild symptoms that progress (in some cases) to the point of dyspnea and shock [11] . Most common complaints are fever (almost universal), cough, which may or may not be productive, whereas myalgia and fatigue are relatively common conditions [12] ....", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 177, "answer": "In symptomatic COVID-19 patients, illness may evolve over the course of a week or longer, beginning with mild symptoms that progress (in some cases) to the point of dyspnea and shock [11] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...2 (SARSCoV-2): Facts and myths 49 In addition, most studies, especially those with a large patient population, were conducted in China, and the study of asymptomatic carriers was limited. More studies are needed to clarify the epidemiologic characteristics of COVID-19 and to identify the risk and prognostic factors of patients infected with SARS-CoV-2. Second, Zou et al. reported that the viral load detected in asymptomatic patients was similar to that found in symptomatic patients; however, the viral loads from patients with severe...", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 178, "answer": "More studies are needed to clarify the epidemiologic characteristics of COVID-19 and to identify the risk and prognostic factors of patients infected with SARS-CoV-2."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...column reflect confidence interval, credible interval, standard error or range reported by each study referenced. Best estimate (Used in Figure 2 ) Plausible range (Used in Figure 3 ) Mean incubation period 5.5 days Sensitivity: 4.5 or 6.5 Clinical data: 83% fever, 67% cough, n = 6 (Chan et al., 2020) 83% fever, 82% cough, n = 99 98% fever, 76% cough, n = 41 43.8% fever at hospital admission, 88.7% fever during hospitalization, n = 1099 Active monitoring after repatriation flights or on cruise ships: % asymptomatic at diagnosis 31.2% (111/355) (Japan Ministry of Health, Labor and Welfare, 2020) 65.2% (5 of 8) (Nishiura et al., 2020) 70.0% (7 of 10) We assume a low percentage, as no specific risk factors have been identified, and known times or sources of exposure are rarely reported in existing line lists....", "qas": [{"question": "What is risk of fatality among symptomatic hospitalized COVID-19 patients?", "id": 179, "answer": "Mean incubation period 5.5 days Sensitivity: 4.5 or 6.5 Clinical data: 83% fever, 67% cough, n = 6 (Chan et al., 2020) 83% fever, 82% cough, n = 99 98% fever, 76% cough, n = 41 43.8% fever at hospital admission, 88.7% fever during hospitalization, n = 1099 Active monitoring after repatriation flights or on cruise ships: % asymptomatic at diagnosis 31.2% (111/355) (Japan Ministry of Health, Labor and Welfare, 2020) 65.2% (5 of 8) (Nishiura et al., 2020) 70.0% (7 of 10)"}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...health authorities must cope with the uncertainty in the risk of death from COVID-19, and high-risk individuals should be identified using approaches that can address the abovementioned three problems. Although COVID-19 involves mostly mild infections among the majority of the general population, the risk of death among young adults is higher than that of seasonal influenza, and elderly with underlying comorbidities require additional care. The novel coronavirus disease that appeared in late 2019 (COVID-19) has spread to the majority of East and Southeast Asian countries, and has resulted in a substantial number of...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 180, "answer": "Although COVID-19 involves mostly mild infections among the majority of the general population, the risk of death among young adults is higher than that of seasonal influenza, and elderly with underlying comorbidities require additional care."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...epidemic, health officials will need to confront the uncertainty in the risk of death, and prompt identification of high-risk individuals using the approaches covered in this article is needed. Subjectively, COVID-19 involves mild infections among the general population, but the risk of death among young adults is higher than for seasonal influenza, and the mortality among older adults with comorbidities requires close attention. The authors declare no conflict of interest....", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 181, "answer": "Subjectively, COVID-19 involves mild infections among the general population, but the risk of death among young adults is higher than for seasonal influenza, and the mortality among older adults with comorbidities requires close attention."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...In addition to quantifying the overall risk of death, future research must identify groups at risk of death (e.g., the elderly and people with underlying comorbidities) [22, 23] . Moreover, considering that about 9% of all infected individuals are ascertained and reported [24] , the infection fatality risk (IFR), i.e., the risk of death among all infected individuals, would be on the order of 0.5% to 0.8%. Our estimated R 0 range of 1.6-4.2 for COVID-19 is consistent with other preliminary estimates posted on public domains [25] [26] [27] [28] , and is comparable to the...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 182, "answer": "Moreover, considering that about 9% of all infected individuals are ascertained and reported [24] , the infection fatality risk (IFR), i.e., the risk of death among all infected individuals, would be on the order of 0.5% to 0.8%."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...disease that appeared in late 2019 (COVID-19) has spread to the majority of East and Southeast Asian countries, and has resulted in a substantial number of deaths [1] . To understand the severity of infection, i.e., the virulence of the causative agent of COVID-19, the common epidemiological practice is to estimate the case fatality risk (CFR) as the risk of death among cases (for the sake of practical interpretation, we refer to it as the case fatality risk rather than the case fatality rate [2] ). Depending on the CFR value, the government response toward COVID-19 may vary, and estimates of CFR can also influence the strictness of policy judgement and the extent of containment...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 183, "answer": "To understand the severity of infection, i.e., the virulence of the causative agent of COVID-19, the common epidemiological practice is to estimate the case fatality risk (CFR) as the risk of death among cases (for the sake of practical interpretation, we refer to it as the case fatality risk rather than the case fatality rate [2] )."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Early \"awake ECMO\" treatment may be considered in the group of younger patients without extrapulmonary organ disorder or serious co-infection, who are expected to gain more benefits. [15, 16] Owing to the infectivity of 2019-nCoV, ECMO poses a high risk when it is performed for COVID-19 patients, which might produce various body fluid splashes, including airway secretions, blood, and others. Therefore, standardized protocols and protective measures should be reevaluated for implementation and management of ECMO for COVID-19 patients. To minimize the risk of nosocomial infections in medical staff and...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 184, "answer": "Owing to the infectivity of 2019-nCoV, ECMO poses a high risk when it is performed for COVID-19 patients, which might produce various body fluid splashes, including airway secretions, blood, and others."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Currently, there are data suggesting that there may be super-transmission events in COVID-19 transmission, and the entire range of interpersonal transmission capabilities of COVID-19 remains unknown [8] [9] . In addition to the fragility of medical institutions in the face of the new coronavirus epidemic, the risk of infection complications among hospital populations is also greatly increased [10] [11] . What we need to do now is to continue to strengthen prevention and control measures, actively strengthen patient admission, diagnosis, and treatment. Our results showed the following epidemiological characteristics...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 185, "answer": "In addition to the fragility of medical institutions in the face of the new coronavirus epidemic, the risk of infection complications among hospital populations is also greatly increased [10] [11] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...presents the estimates of epidemiological characteristics of COVID-19 infections that are key parameter for studies on incidence, case fatality, and epidemic final size, among other possibilities [7, 11] . From the 95th percentile estimate of the incubation period we found that the length of quarantine should be at least 14 days, and we stress that the 17-24-day time delay from illness onset to death must be addressed when estimating COVID-19 case fatality risk. This study was made possible only through open sharing of case data from China and other countries where cases were diagnosed. Continued communication of dates and other details related...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 186, "answer": "From the 95th percentile estimate of the incubation period we found that the length of quarantine should be at least 14 days, and we stress that the 17-24-day time delay from illness onset to death must be addressed when estimating COVID-19 case fatality risk."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...In conclusion, this retrospective, single-center study of 41 confirmed COVID-19 patients has showed the correlation between clinical characteristics and cardiac injury of COVID-19. The high risk factors of cardiac injury including tachycardia, TnI elevation and low EAT density in CT scan, have been observed in the severe and critical COVID-19 patients. Our results suggested that the more attentions shall be applied to protect heart functions, particularly for All rights reserved. No reuse allowed without permission. the author/funder, who has granted...", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 187, "answer": "The high risk factors of cardiac injury including tachycardia, TnI elevation and low EAT density in CT scan, have been observed in the severe and critical COVID-19 patients."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Novel Coronavirus Disease (COVID-19) From (5) , parameters that govern the coefficients a k are estimated, allowing for prediction of risk of death depending on age and underlying comorbidities. Using (5) with application to MERS, the risk of death among patients older than 60 years of age was estimated to be 9.3 times greater than those in the younger age group [16] . Likewise, the CFR for SARS was estimated to be 43.3% in those aged 60 years or older and 13.2% among those younger than 60 years of age [15] ....", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 188, "answer": "Using (5) with application to MERS, the risk of death among patients older than 60 years of age was estimated to be 9.3 times greater than those in the younger age group [16] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19) To understand the severity of infection for a given disease, it is common epidemiological practice to estimate the case fatality risk, defined as the risk of death among cases....", "qas": [{"question": "What is risk of fatality among high-risk COVID-19 patient groups?", "id": 189, "answer": "Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)"}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...of females to viral infection is that females have a lot of X chromosome and estrogen that are vital components in development of innate and adaptive immunity [47] . Meanwhile, numbers of patients with COVID-19 infection had chronic comorbidities, mainly hypertension, diabetes and cardiovascular disease, which is similar to MERS-COV population. Those results indicate that older adult males with chronic underlying disease might be more susceptibility to COVID-19 or MERS-COV. CC-BY-NC-ND 4.0 International license It is made available under a...", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 190, "answer": "Meanwhile, numbers of patients with COVID-19 infection had chronic comorbidities, mainly hypertension, diabetes and cardiovascular disease, which is similar to MERS-COV population."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...distributions in the risk of infection can be attributed to immunological features, such as the lower circulation of H1N1 influenza in older individuals due to residual immunity [17] . An immunological explanation of the opposite phenomenon, with a lower susceptibility of younger individuals, seems unlikely, and there is no indication of pre-existing immunity to COVID-19 in humans [10] . Different contact patterns could play a role in a limited outbreak, but not in such a widespread infection, especially as household transmission seems to play a major role [10]...", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 191, "answer": "An immunological explanation of the opposite phenomenon, with a lower susceptibility of younger individuals, seems unlikely, and there is no indication of pre-existing immunity to COVID-19 in humans [10] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Meanwhile, numbers of patients with COVID-19 infection had chronic comorbidities, mainly hypertension, diabetes and cardiovascular disease, which is similar to MERS-COV population. Those results indicate that older adult males with chronic underlying disease might be more susceptibility to COVID-19 or MERS-COV. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity....", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 192, "answer": "Those results indicate that older adult males with chronic underlying disease might be more susceptibility to COVID-19 or MERS-COV."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...from SARS-Cov and MERS-Cov that human populations showed disparities in susceptibility to these viruses. For example, epidemiology studies found that males had higher incidence and mortality rates than females. 1, 2 We believe that the susceptibility to the novel 2019-nCov is also different among population groups. In current severe global emergency situation of 2019-nCov outbreak, it is imperative to identify vulnerable and susceptible groups for effective protection and care....", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 193, "answer": "1, 2 We believe that the susceptibility to the novel 2019-nCov is also different among population groups."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Further, compared to non-smokers, smokers and COPD patients had a higher dipeptidyl peptidase IV (DPP4) expression, which was inversely correlated with lung function and diffusing capacity parameters 16 . Although the relationship between smoking history and susceptibility as well as worse outcomes in COVID-19 remains unclear, we cautioned that the prognosis of COVID-19 in patients with smoking history might be more severe. In our cohort, lymphocytopenia occurred in more than 70% of patients at admission, which is a main laboratory feature in COVID-19 patients 15, 17 . Lymphocytopenia have been identified...", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 194, "answer": "Although the relationship between smoking history and susceptibility as well as worse outcomes in COVID-19 remains unclear, we cautioned that the prognosis of COVID-19 in patients with smoking history might be more severe."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...The four other human coronaviruses In addition, we found that the number of males is more than that of females in either COVID-19 or MERS-COV population. The possible reason of reduced susceptibility of females to viral infection is that females have a lot of X chromosome and estrogen that are vital components in development of innate and adaptive immunity [47] . Meanwhile, numbers of patients with COVID-19 infection had chronic comorbidities, mainly hypertension, diabetes and cardiovascular disease, which is similar to MERS-COV population....", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 195, "answer": "The possible reason of reduced susceptibility of females to viral infection is that females have a lot of X chromosome and estrogen that are vital components in development of innate and adaptive immunity [47] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...basic reproductive ratio can then be estimated from these transmission structures to give us an approximation of the spreading potential of a COVID-19 outbreak in each of these countries. Our estimation process consists of calculating an age-specific susceptibility profile based on epidemiological data from China and the estimated China-level contact matrix [3] . This susceptibility profile can then be combined with the estimated country-level contact matrices from the other countries in Prem et al.'s study [3] to produce age-stratified transmission matrices for...", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 196, "answer": "Our estimation process consists of calculating an age-specific susceptibility profile based on epidemiological data from China and the estimated China-level contact matrix [3] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...1176/1715), of young age (18-44 years) (80%; 1380/1715), 180 working population (68%; 1168/1715). The study sample is comparable to the population in terms of 181 residential district (effect size=0.27). Table 2 Table 3 shows the perceived susceptibility and perceived severity towards COVID-19 among 189 respondents. Most respondents regarded themselves as likely to be infected with likely/likely: 89%), and most considered the symptoms of COVID-19 (if infected) as serious (very 191 serious/serious: 97%)....", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 197, "answer": "Table 2 Table 3 shows the perceived susceptibility and perceived severity towards COVID-19 among 189 respondents."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...1101 significantly higher mortality rate than women in patients with SARS. Older age and male gender are risk factors for worse outcome in patients with COVID. While men and women have the same susceptibility to both SARS-CoV-2 and SARS-CoV, men may be more prone to have higher severity and mortality independent of age and susceptibility. In early December 2019, an outbreak of a novel coronavirus disease in Wuhan city and the rapidly spread throughout China has put the world on alert. High-throughput sequencing has...", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 198, "answer": "While men and women have the same susceptibility to both SARS-CoV-2 and SARS-CoV, men may be more prone to have higher severity and mortality independent of age and susceptibility."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...study, we wish to answer the following question: What conditions or traits may lead to increased ACE2 expression, which may in turn result in greater susceptibility to 2019-nCov infection? Since COVID-19 is a new disease and prior knowledge is lacking, we employed a phenome-wide approach in which a large variety of traits are studied for causal associations with ACE2 expression. This analysis may help to prioritize resources for better prevention of the infection in those susceptible subjects. In addition to diseases, we also studied serum/plasma proteins as exposure, as...", "qas": [{"question": "What do we know about susceptibility of populations for COVID-19?", "id": 199, "answer": "Since COVID-19 is a new disease and prior knowledge is lacking, we employed a phenome-wide approach in which a large variety of traits are studied for causal associations with ACE2 expression."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...size [16], and with a shorter epidemic doubling time as we show in Table 1 . Therefore, timely contact tracing and effectively quarantine were crucial to shutoff the transmission. The simulation results under scenarios (1)-(3) indicate that the public health control measures could effectively mitigate the COVID-19 outbreak on the ship in terms of the final size, see Table 1 . Decreasing the disease transmissibility in terms of R0 could postpone the peak, which may gain valuable time to prepare and allocate the resources in response to incoming patients....", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 200, "answer": "The simulation results under scenarios (1)-(3) indicate that the public health control measures could effectively mitigate the COVID-19 outbreak on the ship in terms of the final size, see Table 1 ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...(COVID-19) Each of these requires a sophisticated modeling approach and detailed case dataset in addition to a simple division of the number of deaths by the number of cases. In the ongoing epidemic of COVID-19, all these aspects have not yet been fully addressed, although the global public health community is obliged to continually confront the epidemic and make political decisions encompassing travel restrictions, containment measures, and mitigation strategies. To accomplish the scientific assessment of the severity and sufficiently understand pitfalls surrounding the associated debates, we aim to guide the readers to understand the likely severity of COVID-19...", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 201, "answer": "In the ongoing epidemic of COVID-19, all these aspects have not yet been fully addressed, although the global public health community is obliged to continually confront the epidemic and make political decisions encompassing travel restrictions, containment measures, and mitigation strategies."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...or selfprotective measures, the epidemic was likely to grow in a relatively large rate. The R0 estimates and the rapid growth of epidemic curves both indicates the disease transmissibility. Thus, control measures as well as self-administered protective actions are crucial to reduce the transmissibility of COVID-19 and thus mitigate the outbreak size and prevent for further burden. Given the superspreading is unlikely to occur, we can be confident to control the COVID-19 outbreak by reducing the reproduction number to below unity. ....", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 202, "answer": "Thus, control measures as well as self-administered protective actions are crucial to reduce the transmissibility of COVID-19 and thus mitigate the outbreak size and prevent for further burden."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Containment of respiratory infections is particularly difficult if they are characterized by relatively mild symptoms or transmission before the onset of disease (25) . Intensive control measures, including travel restrictions, have been implemented to limit the spread of COVID-19 in China. Here, we showed that this combination of interventions was successful in mitigating the spread and reduce local transmission of COVID-19 in China although it is not possible to definitively...", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 203, "answer": "Intensive control measures, including travel restrictions, have been implemented to limit the spread of COVID-19 in China."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Objective: Establishing a social contact data sharing initiative and an online tool to assess mitigation strategies for COVID-19. Results: Using our online tool and the available social contact data, we illustrate that social distancing could have a considerable impact on reducing transmission for COVID-19....", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 204, "answer": "Objective: Establishing a social contact data sharing initiative and an online tool to assess mitigation strategies for COVID-19."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Does the reduction of the emergency response level mean that people can fully or partially relieve from self-production? When can people return back to normal life? The aim of this work is to evaluate the effectiveness of varied interventions and selfprotection measures, estimate the risk of partial lifting control measures and predict the epidemic trend of the virus in mainland China excluding Hubei province by establishing a COVID-19 transmission model incorporating the intervention measures implemented and fitting the data obtained from the National Health Commission of China (NHCC). Based on the clinical progression of the disease, epidemiological status of the individuals and intervention measures (including travel restriction, body temperature measurement, close contact tracing, self-isolation and protection, etc.),...", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 205, "answer": "The aim of this work is to evaluate the effectiveness of varied interventions and selfprotection measures, estimate the risk of partial lifting control measures and predict the epidemic trend of the virus in mainland China excluding Hubei province by establishing a COVID-19 transmission model incorporating the intervention measures implemented and fitting the data obtained from the National Health Commission of China (NHCC)."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...pathogen [10] , investigate the structure of virions by electron microscopy [11] , and generate other data that contributed to the correct identification of the causative agent [12] . Meanwhile, public health specialists implemented control measures and mitigation procedures to prevent the spread of the disease [13] . The Bioinformatics Resource Centers (BRC) for Infectious Diseases [15] [16] [17] were created to serve as database resources for the integration of research and surveillance data being generated by...", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 206, "answer": "Meanwhile, public health specialists implemented control measures and mitigation procedures to prevent the spread of the disease [13] ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...Our findings contribute to improved understanding of integrated NPI measures on COVID-19 containment and can help in tailoring control strategies across contexts. Given that effective COVID-19-specific pharmaceutical interventions and vaccines are not expected to be available for months, NPIs are essential components of the public health response to the ongoing outbreaks. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity....", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 207, "answer": "Given that effective COVID-19-specific pharmaceutical interventions and vaccines are not expected to be available for months, NPIs are essential components of the public health response to the ongoing outbreaks."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...To minimize the risk of hospital-based transmission of SARS-CoV-2, the Ministry of Health of Singapore has restricted the movement of patients and staff across hospitals (20) . Also, because multiple unlinked community cases of COVID-19 have been reported (21) , various social distancing measures have been put in place including advising the public against large social gatherings in order to mitigate the risk of community transmission (22, 23) . These social distancing measures reduce the risk of onward transmission not only within Singapore, but also beyond the borders of this highly connected nation (24)....", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 208, "answer": "Also, because multiple unlinked community cases of COVID-19 have been reported (21) , various social distancing measures have been put in place including advising the public against large social gatherings in order to mitigate the risk of community transmission (22, 23) ."}]}]}, {"title": "synthetic", "paragraphs": [{"context": "...massive population flow has brought great challenges for disease prevention and control. This virus can be transmitted from human to human and no effective treatment drug has been found. The most effective prevention and control measures are to find suspected patients and close contacts, confirm patients and virus carriers, and block the transmission through isolation, disinfection, and personal protection. Therefore, early detection, isolation, and treatment of patients are the key measures to control the source of infection and reduce the infection rate....", "qas": [{"question": "What are public health mitigation measures effective for controlling COVID-19?", "id": 209, "answer": "The most effective prevention and control measures are to find suspected patients and close contacts, confirm patients and virus carriers, and block the transmission through isolation, disinfection, and personal protection."}]}]}]}